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ISOLATION AND CHARECTERIZATION OF UROPATHOGENS 
WITH  CONVENTIONAL AND CHROMOGENIC MEDIA AND 
DETECTION OF EXTENDED SPECTRUM BETA LACTAMASES 
ABSTRACT 
Background : Urinary  tract  infections  are  one  of  the  most  common  
bacterial  infections  in  humans. It  is  also  one  of  the  common  specimens  
sent  to  the  laboratory. Worldwide,  the  data  show  that  there  is  an  
increasing  resistance  among  the  organisms  which  cause  UTI. A study  on  
the  changing  antibiotic  resistance  pattern  is  pertinent  for  an  appropriate  
treatment  and  for  the  prevention  and  control  of  the  different  mechanisms  
of  resistance. 
Aim : To  compare  the  efficacy  of  chromogenic  media  with  conventional 
media  for  the  isolation  and  identification  of  uropathogens  and  also  to  
detect  their  antibiotic  susceptibility  pattern. To  detect  the  extended  
spectrum  betalactamases  production  among  Escherichia coli, Klebsiella  
pneumoniae  and  Proteus by  double  disc  synergy  test  and  Etest.   
Methods :  A  total  of  422  samples  collected  from  various  departments  
during  the  period  of  August  2013- September 2014 were  processed  in  
blood  agar, MacConkey  agar  and  chromogenic  agar. Isolation  rate  was  
compared  and  antibiotic  susceptibility  tests  were  done. ESBL  isolates  were  
detected  using  DDST  and  E test. 
Results : Escherichia  coli  was  the  common  isolate. Chromagar  detected  all  
the  uropathogens . Escherichia  coli  was  the  most  common  ESBL  producer 
(67.5%). E test  was  more  sensitive  than  DDST in  detecting  ESBL.  
Conclusion : ESBL  isolates  are  more  susceptible  to  Meropenem, 
Nitrofurantoin, and  Amikacin. DDST  can  also  be  adopted  as  a  method  of  
ESBL  detection.  
Key  words : UTI, CHROM AGAR, ESBL, AST 
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INTRODUCTION 
Urinary tract infections(UTIs)   are one of  the most prevalent  
bacterial infections in the developing countries. Among the  hospital  
acquired  infections , UTI s  contribute  to  35-40%  of  them. They  also  
cause  morbidity  and  increased  mortality  in  hospitalized  patients.1 It  
has  a  spectrum  of  clinical  entities  with  severity  ranging  from  
asymptomatic  infection  to  acute  pyelonephritis  with  sepsis.  
The prevalence of UTI  is age and sex dependent;  with more of 
sex predilection  towards females . The anatomy of female urethra is of 
particular importance to the pathogenesis of UTIs. Because  of the short 
urethra and its close proximity to the  perianal  region, bacteria can reach 
the bladder more readily and cause infection in females .Also the 
anatomic and hormonal changes during pregnancy increase the incidence 
of bacteriuria. Other predisposing factors include diabetes, urinary 
calculi, structural and functional abnormalities of the urinary tract, renal 
disease and indwelling urinary catheters. Bacteria can invade and cause 
infection by two major routes. The ascending route is the most common 
route of spread of infections whereas hematogenous  spread occurs as a 
result of  bacteremia. 
Urine samples  are  amongst the most  common specimens  sent  to 
the microbiology  laboratory. Only a small percentage  of urine samples  
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give  significant  growth. Considerable  amount  of  time  is  spent  in  
evaluating  samples  that  do  not  have  clinical  utility.2.  Rapid  
identification  of  the  causative  organisms  is  necessary  especially  in  
hospitalized  patients as  increase  in  resistant  organisms  cause  
difficulty  in  treatment.3  It provides useful information  for  the  clinician  
to  select  appropriate  antibiotics  prior  to  the  results  of susceptibility  
tests .  Therefore  any  medium  with a  ability  to  show  results within  a 
short time ( i.e)  reduced  turnaround time  and   laboratory cost  is 
preferred.   
The  main  causative  agent  of  urinary  tract  infection  is 
Escherichia coli. Other Gram negative organisms like  Klebsiella, 
Proteus,  Pseudomonas,  Enterobacter   and Gram positive organisms 
such  as  Enterococcus  faecalis  and  Staphylococcus saprophyticus  are 
also responsible  for the remainder of the  UTIs .                    
Most  of  the  laboratories  use  blood agar,  MacConkey  agar  or  
Cystine  Lactose  Electrolyte  Deficient  Agar (CLED) for  primary  
inoculation  of  urine  samples . Though blood agar is used as an enriched 
medium it lacks the ability to  primarily  differentiate  between Gram 
positive or Gram negative organisms, which  needs  further identification 
tests and delay in result. Swarming  of  Proteus  species  is  also  not  
prevented  in  blood  agar. Lactose  fermenting  and  non lactose  
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fermenting organisms  are  differentiated  by  MacConkey  agar  using    
neutral red  indicator4.  Hence  Blood agar  and  MacConkey agar 
medium are  used  together  conventionally for the  isolation  of  urinary  
pathogens.  CLED (Cystine Lysine Electrolyte Deficient)  medium  
supports  the  growth  of  Staphylococci, Streptococci and  Candida.   
MacConkey  agar and  CLED  agar media  distinguishes Lactose  
fermenting  and  non lactose  fermenting  colonies  and also prevent 
swarming of Proteus spp.. But  further differentiation of  organisms  are  
not  possible  because  these  media  lack  the   genus or species  specific  
indicator  properties .Also Gram positive organisms like Enterococci and 
Streptococci may be obscured by the heavy growth of 
Enterobacteriaceae.Hence it may be difficult to identify  the predominant 
organism in mixed cultures5 
Of late,  Chromogenic media, as  an  alternative are  available  to 
overcome  these limitations. These  media  help  in  identification  of  
pathogens  on  the  primary  plate  itself ,  by  the  typical  colour  and  
morphology  produced  by  the  organisms  there by  reducing  the  
number  of  confirmatory  tests.  They also  have the  advantage  that they 
support the growth of all uropathogens6 and prevent swarming of Proteus. 
Bacteria  have  many  enzymes  like β glucuronidase,and  β 
galactosidase   for  their  physiologic  functions. Chromogenic  substrates  
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incorporated  in  the  Chromogenic media  are  specifically  broken  down  
by  the enzymes  present  in  the  particular  bacteria, imparting  a distinct  
color  to  the growing  bacterial  colony, which  can be   observed  
visually.   Chromogenic media  help in  rapid  identification  of  the  
organisms . This  in  turn  may  help  in  initiating appropriate  antibiotics 
earlier. These  media  also  provide  increased  sensitivity in identification  
of  some  Gram positive  cocci  (e.g.,Enterococci)  in  mixed  cultures.  
Antimicrobial resistance  is  a  growing  threat worldwide. 
Resistance   mechanisms  are  found  for  almost  every  class  of  
antibiotic  agents.  The  production  of  beta  lactamases are  the  
important  mechanism  of  resistance  in  Gram  negative  bacteria.    The  
production  of  extended-spectrum β-lactamases  (ESBL)  is  an  
important  mechanism  of  resistance  to  third-generation  cephalosporins  
which  are  widely  used in urinary tract infections because of  lesser 
nephrotoxicity effects. During  last  few  decades  ESBL  producing  
Gram-negative  organisms  have  been  a  major  problem  in  many  
settings.   
Extended spectrum beta lactamases  (ESBL) are  enzymes  capable  
of  conferring bacterial resistance to the penicillins ,first, second and third 
generation cephalosporins and aztreonam(but not the cephamycins or 
carbapenems)  by  hydrolysis  of  these  antibiotics. They  are  inhibited  
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by  beta lactamase  inhibitors  such  as  clavulanic  acid,  sulbactum  and 
tazobactum  They  are  thought  to  have  evolved  by  mutation  of  the 
TEM  and  SHV  genes  .Organisms  responsible for  UTIs such  as  
E.coli and Klebsiella produce  these  enzymes. These  enzymes  are  
plasmid borne  and  confer  multi drug   resistance, difficulty  in  
treatment and  increased  morbidity  and  mortality .Detection  of  ESBLs 
in  urine  samples  are  important  because  they represent  
epidemiological  marker  of  colonization 7.  Disc  diffusion  methods  
have  been  proposed  by  CLSI  for  the  detection  of  ESBLs  in  
organisms  such  as  Klebsiella, Escherichia coli  and  Proteus. The 
reduction  in  the  zone  diameters  of  antibiotics   such  as  cefpodoxime, 
ceftriaxone, ceftazidime, cefotaxime  or aztreonam indicate ESBL 
production.  Testing  with  more  than  one  drug  increases  the  
sensitivity of detection. Phenotypic  confirmatory  methods, such as 
double  disc  synergy  test,  combined  disk method and E test 
(epsilometry methods) are available which are  based on in vitro 
inhibition  of  ESBLs  by  betalactamase  inhibitors,  Genotypic  detection 
methods  are  useful  in  distinguishing  between  specific  enzymes  
(TEM, SHV, CTX-M)  responsible  for  ESBL  production  and  for  
epidemiological  purposes. 
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As  the  specimen  load  (urine  specimen)  received  in  the  
laboratory  have  been  increasing  and  the  multidrug  resistant  
organisms  causing  serious  infections  are  on  the  rise,  this  study  has  
been  taken  up.  The  spectrum  of  organisms  causing  UTI  in  our  
hospital  with  their  antibiotic  susceptibility  pattern  has  been  
evaluated. In  this  study  phenotypic  methods  such  as  double  disc  
synergy  tests  and  Etests  are  used  in  the  detection  of  ESBLs  among  
Gram  negative  isolates.                   
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AIMS  AND  OBJECTIVES 
AIM : 
To  isolate  the  uropathogens  in  conventional  media  such  as  
blood agar,  MacConkey agar  and chromogenic agar, and  to  compare  
the  rate  of  isolation.  To  study the antibiotic  susceptibility  pattern of 
the  organisms and detection  of  extended  spectrum  beta lactamases in 
the Gram negative isolates. 
 SPECIFIC OBJECTIVES : 
1. To  isolate  and  characterize  the  uropathogenic  organisms  in  
blood agar ,  MacConkey agar  and  chromogenic  agar. 
2. To compare  the  isolation  rate  in chromogenic  agar   and  
conventional  agar. 
3. To  study  the  antibiotic  susceptibility  pattern  of  the  isolates. 
4. To  detect  the  extended  spectrum  beta  lactamases  among  the  
isolates. 
5. To confirm  the  extended spectrum  beta  lactamases  producing  
strains   with  double  disc  approximation  test  and  Etest  or  
epsilometer  test 
6. To  study  the  resistance  pattern  of  the  extended  spectrum  beta  
lactamases. 
  
  
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
8 
 
REVIEW  OF  LITERATURE 
Urinary  tract  infection  can  be  asymptomatic  (subclinical  
infection)  or  symptomatic  (disease).  The  term  Urinary  tract  infection  
denotes  a  variety  of  clinical  entities,  including  asymptomatic  
bacteriuria,  cystitis,  prostatitis  and  pyelonephritis. 
Cystitis  refers  to  symptomatic  infection  of  the  bladder  and  
pyelonephritis  denotes  symptomatic  infection  of  the  kidneys. 
Uncomplicated  urinary  tract  infection  refers  to  infection  in  a  
structurally  and  neurologically  normal  urinary  tract. 
Complicated  urinary  tract  infection  refers  to  infection  in  a  
urinary  tract  with  functional  or  structural  abnormalities,  indwelling  
catheters  and  calculi. 
Recurrent  urinary  tract  infections  may  be  caused  by  relapses  or  
reinfections  . 
Relapse  is  caused  by  the  persistence  of  microorganism  in  the  
urinary  tract  that  was  present  before  therapy  was  started. 
Reinfection  is  a  recurrence  of  bacteriuria  with  a  different  
microorganism  or  with  a  same  microorganism,  which  may  have  
persisted  in  vagina  or  faeces. 
Urosepsis  is  the  sepsis  syndrome  caused  by  urinary  tract  infection. 
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Acute  lobar  nephronia,  also  called  focal  bacterial  nephritis,  is  
inflammation  and  edema  of  one  kidney  lobe  in  a  patient  with  acute  
pyelonephritis.8 
EPIDEMIOLOGY 
Urinary  tract  infections  are  the  most  common  bacterial  
infections.  Approximately  10%  of  people  experience  urinary  tract  
infection  during  their  life  time.9  During  the  first  year  of  life  the  
incidence  of  urinary  tract  infection  in  males  and  females  are  about  
2%.  The  incidence  in  males  become  relatively  low  after  one  year  
of  age  until  about  sixty  years,  when  hypertrophy  of  prostate  
interferes  with  bladder  emptying.  The  incidence  in  females  increases  
with  age  to  as  high  as  10%.Short  urethra,  close  proximity  to  
perirectal  region,  sexual  activity,  hormonal  changes  during  
pregnancy  all  contribute  to  the  higher  prevalence  of  urinary  tract  
infections  among  females.   
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Age  related  risk  of  acquiring  UTI10 
Age Prevalence Predisposing  factors 
Neonate 1%  males,  females Congenital  urethral  
valve  or  stenosis 
School  children 1-2%  in  girls,  0.03%  
in  boys 
30-50%  have  vesico  
uretrric  reflex 
Young  adults 1-3%  in  women,  
0.1%  in  men 
Sexual  activity,  altered  
vaginal  flora 
Older  adults 20%  in  women,  
10%  in  men 
Bladder  prolapsed,  
calculi,  prostatic  
hypertrophy 
 
Risk  factors  for  urinary  tract  infections 
1.  Lack  of  circumcision. 
2.  Previous  urinary  tract  infection 
3.  Urologic  instrumentation  or  surgery 
4.  Urethral  catheterization 
5.  Neurogenic  bladder 
6.  Renal  transplantation 
7.  Diabetes 
8.  Pregnancy 
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9.  Bladder  prolapse 
10.  Prostatic  enlargement. 
Etiology 
In  acute  uncomplicated  cystitis,  Escherichia  coli  accounts  for  
75-90%  isolates,  Staphlococcus  saprophyticus  for  5-15%(in  younger  
women),Klebsiella  ,Proteus  ,Enterococcus  ,Citrobacter  and  other  
organisms  for  5-10%. 
In  uncomplicated  pyelonephritis  E.coli  is  the  predominant  
isolate. 
In  complicated  UTI(catheter  associated)  E.coli  is  the  
predominant  organism,  but  organisms  such  as  Klebsiella,  Proteus,  
Citrobacter,  Acinetobacter,  Morganella  and  Pseudomonas  are  also  
isolated.  Gram  positive  organisms  such  as  Enterococci,  
Staphlococcus  aureus  and  yeasts  also  play  an  important  role  in  
complicated  UTI.11 
Adeno  virus  type  11  causes  epidemic  haemorrhagic  cystitis  in  
children  ,  particularly  in  boys.64 
Pathogenesis 
Urinary  tract  infections  are  caused  by  the  result  of  interaction  
of  bacterial  virulenc ,  as  opposed  by  host  defence  mechanisms.  The  
three  routes  by  which  bacteria  can  enter  and  spread  within  the  
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urinary  tract  are  the  hematogenous, ascending  and  lymphatic  
pathways. 
Ascending  route:  Colonization  of  the  vagina  and  periurethral  area  
with  the  organisms  from  the  intestinal  flora  is  the  initial  step  in  the  
pathogenesis  of  UTI.  Sexual  intercourse,  nonoxynol-9  in  
contraceptives,  which  is  toxic  to  normal  vaginal  flora  ,estrogen  
deficiency  in  post  menopausal  women  and  short  urethra  in  females  
contribute  to  the  increased  vaginal  colonization  of  E.coli  and  
bacteriuria. 
Anatomical  and  functional  abnormalities:  Any  condition  that  
produces  urinary  stasis  or  obstruction  predisposes  to  UTI.Foreign  
bodies  such  as  stones,  urinary  catheters,  vesicoureteral  reflux,  
ureteral  obstruction  secondary  to  prostatic  hypertrophy,  neurogenic  
bladder,  urinary  diversion  and  surgery  create  an  environment  
favourable  to  UTI.  In  these  conditions  ,E.coli  strains  lacking  typical  
urinary  virulence  factors  cause  infection.  Decreased  ureteral  tone  
and  inhibition  of  ureteral  peristalsis  are  important  pathogenesis  of  
pyelonephritis  in  pregnant  women. 
Hematogenous  route:  In  patients  with  Staphylococcus  aureus  
bacteremia  or  endocarditic, kidney  is frequently the site  of  abscess  
formation. Infection  of  the  kidney  with  gram  negative  bacilli  such  
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as  Salmonella  results  from  bacteremia  .Less  than  2%  of  urinary  
tract  infections  occur  by  hematogenous  route.  The  infections  with  
Candida  occur  mostly  by  hematogenous  route.  The  presence  of  
Candida  in  a  noninstumented  immunocompetent  patient  indicates  
either  contamination  or  widespread  dissemination. 
Lymphatic  route:  The  increased  pressure  in  the  bladder  causes  
lymphatic  flow  to  be  directed  towards  the  kidney  .Thus  the  
ascending  pathway  is  the  most  important. 
UROVIRULENCE  IN  BACTERIA 
The  commonest  organism  causing  urinary  tract  infections  are  
E.coli. Only  a  few  serogroups  of  E.coli  -01, 02, 06, 07, 08, 075, 0150, 
018 ab  cause  infection.  Serotypes  such  as  O,K  and  H  causes  severe  
pyelonephritis.  These  isolates  express  chromosomally  encoded  
virulence  markers.12  The  virulence  genes  commonly  associated  with  
uropathogenic  E.coli  include  P  fimbriae  (pap),  aerobactin  (aer),  
afimbrial  adhesion  1  (afal),  aerobactin  (aer),  type  1  fimbriae,  
hemolysin  (hly),  Sfimbriae  (sfa),  cytotoxic  necrotizing  factor  
1(cnf1),  adhesins  and  fimbriae  (1,5).13  These  virulence  genes  help  
in  bacterial colonization in  urinary  epithelium  causing  severe  disease. 
The  p  fimbriae  attach  to the globoseries receptors present in the  P  
blood  group  antigens  of  erythrocytes  and  uroepithelial  cells.  They 
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augument  the  infection  by  remaining  longer in the intestinal  tract  and  
spreading  efficiently  to  the  urinary  tract  for  colonizing  and  
producing  ascending  infection.  They  are  mannose  resistant. 
Type  1  fimbriae  are  mannose  sensitive.  They  bind  to  mannose  
epitopes  on  secretory  IgA  ,  urinary  mucus,  Tamm-Horsfall  protein,  
bladder  uroplakin  protein  and  fibronectin.  Adherent  bacteria  multiply  
into  biofilm  like  inclusions  or  enter  into  a  quiescent  phase  for  
reemergence.  This  may  contribute  to  clinical  relapse.  Bacterial  
adherence  to  urinary  catheters  is  also  type  1  fimbriae  dependent.14  
Type  3  fimbriae  contribute  to  biofilm  formation  and  urethral  
catheter  related  infections.  Other  adhesins  like  type1c,G,Dr  fimbriae  
and  M  and  X  adhesins  .Dr  fimbriae  positive  E.coli  persist  in  renal  
infections  and  play  a  role  in  chronic  pyelonephritis  and  interstitial  
nephritis.All  these  adhesins  bind  to  uroepithelial  cells  and  cause  
recurrent  urinary  tract  infections. 
Organization  of  virulence  factors:  In  uropathogenic  Escherichia  
coli  virulence  factors  like  fimbriae  and  hemolysin  are  clustered  in  
segments  of  DNA  ,termed  pathogenicity  islands.  An  organism  may  
contain  more  than  one  of  these  islands  .  A  cross  talk  between  the  
genes  encoding  the  pathogenicity  islands  and  chromosomal  loci  has  
been  described. 
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Other  uropathogens  like  Proteus  mirabilis  and  Klebsiella  
species  also  have  showed  the  adherence  in  the  pathogenesis  of  
urinary  tract  infections. 
Other  virulence  factors:  Motile  bacteria  can  ascend  against  the  
flow  of  urine.  Endotoxins  of  Gram-negative  bacilli  decrease  uretral  
peristalsis  and  contribute  to  renal  parenchymal  inflammatory  
response. 
In  Proteus  species,  and  in  Staphylococcus  saprophticus  the  
production  of  urease  increases  the  urinary  pH  and  the  increased  
concentration  of  ammonia  lead  to  precipitation  of  struvite  or  
carbonate-apatite.  Also  urease  may  increase  the  adhesion  of  bacteria  
to  the  urothelial  cells. 
The  K  capsular  antigen  protects  bacteria  from  leukocyte  
phagocytosis.  The  hemolysin  produced  facilitates  tissue  invasion  and  
causes  renal  tubular  and  parenchymal  damage,  making  iron  available  
to  invading  E.coli.  Aerobactin,  an  iron  scavenging  protein  or  
siderophore  is  present  in  the  uropathogenic  strains  of  E.coli.  
Uropathogenic  strains  have  a  lot  of  iron  acquisition  systems  than  
fecal  or  commensal  strains,  which  shows  the  adaptation  to  the  iron  
limiting  urinary  environment.15   
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In  Staphlococcus  saprophyticus  ,a  hemagglutinin  that  
recognizes  a  protein  receptor  on  the  erythrocyte  is  present.  This  
adhesin  is  responsible  for  the  attachment  to  uroepithelial  cells.In  
Enterococci  an  aggregation  substance  that  contains  an  RGDS  and  
RGDV  motif  is  expressed  which  binds  to  cells  expressing  integrins  
which  are  the  receptors. 
The  susceptibility  to  infection  is  different  for  various  parts  of  
the  urinary  tract.  The  medulla  is  easily  susceptible  to  infection  
because  of  the  high  concentration  of  ammonia,high  osmolality,  low  
pH,  and  low  blood  flow  which  may  inactivate  the  complement. 
Anti  bacterial  host  defences  in  the  urinary  tract 
The  bacterial  adherence  to  uro  epithelial  cells  are  inhibited  by  
Tamm-Horsfall  protein,  bladder  mucopolysaccharide,  secretory  
immunoglobulin  A,  lactoferrin,  polymorphonuclear  neutrophils  and  
cytokines. 
Host   signalling  in  response  to  uropathogens 
Toll-like  receptor  4  (TLR4)  is  essential  for  signalling  innate  
immunity  in  response  to  UTI.  The  enhanced  expression  of  TLR  4  
causes  the  secretion  of  interleukin-6,  and  interleukin-8  which  
prevents  the  invasion  of  the  bacteria  and  helps  in  expulsion  of  
uropathogenic  organisms.16TLR1,TLR2  are  also  secreted  in  response  
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to  urinary  tract  infections.  Polymorphism  in  the  interleukin  8  
receptor  gene  CXCR  1  impairs  neutrophil  dependent  host  defence  
against  bacterial  invasion  and  increases  the  chance  of  infection.17 
  Immunity 
Systemic  antibody  response  is  produced  in  acute  
pyelonephritis.  Antibodies  against  type 1 fimbriae, P fimbriae ,Kantigen  
and  O antigen  are  produced   .Ig  M  antibodies  are  found  in  response  
to  upper  tract  infections.  High  level  of  Ig  G  antibodies  correlate  
with  the  progression  of  renal  parenchymal  destruction.  Lower  UTI  
is  associated  with  a  reduced  serologic  response,  indicating  the  
superficial  nature  of  the  infection  .Secretory  IgA  is  also  secreted  in  
response  to  the  microorganisms.  In  spite  of  the  urinary  antibody  
response,  the  protective  role  is  not  clear.  Antibodies  may  be  useful  
in  limiting  the  damage  produced  in  the  kidney  and  in  preventing  
the  colonization  which  precedes  recurrence. 
Structural  abnormalities  which  produce  obstruction  to  urinary  
flow,  result  in  stasis  which  in  turn  increase  the  susceptibility  to  
infection.   
Extra  renal  obstructions  like  congenital  anomalies  of  the  
urethra  or  ureter,  such  as  stenosis,  valves or  calculi, uterine  prolapse 
, benign  prostatic  hypertrophy and  intrarenal  obstructions  such  as      
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nephrocalcinosis, analgesic  nephropathy, uric  acid  nephropathy,  ,  poly  
cystic  kidney  disease, hypokalemic  nephropathy, inhibit the normal  
urinary  flow  and  increase  the  susceptibility  to  infection.  
Vesicoureteral  reflux , especially  in  children  contribute  to  infection  
of  ureter  and  kidneys  which  result  in  subsequent  scarring. 
Patients  with  incomplete  emptying  of  the  bladder  or  
neurologic  abnormalities  like   diabetic  neuropathy  and  spinal  cord  
injuries  are  prone  to  frequent  urinary  tract  infections.18   
Genetic  factors  like  decreased  expression  of  CXCR  1  and  
Toll  like  receptor  4  result  in  decreased  neutrophil  migration  and  
increased  susceptibility  to  asymptomatic  bacteriuria. 
The  spectrum  of  presentation 
 Asymptomatic  bacteriuria 
 Symptomatic  acute  cystitis  and  urethritis 
 Acute  pyelonephritis 
 Acute  prostatitis 
 Acute  urethral  syndrome 
 Septicemia 
Sometimes  urinary  tract  infections  are  classified  as  
complicated  and  uncomplicated.  Uncomplicated  infections  occur  in  
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healthy  females,  occasionally  in  male  infants,  and  adolescents  and  
adult  males. 
Complicated  urinary  tract  infections  occur  with  the  following  
risk  factors: 
 Underlying  diseases  that  predispose  kidney  to  
infection  (diabetes,  sickle  cell  anemia) 
 Kidney  stones 
 Structural  or  functional  abnormalities  of  the  
urinary  tract 
 Indwelling  urinary  catheters. 
Uncomplicated  infections  respond  readily  to  antibiotics  and  
complicated  infections  are  difficult  to  treat  and  have  higher  
morbidity  and  mortality  rates. 
Asymptomatic  bacteriuria19 
It  is  defined  as  ˃ 105  organisms/ml  in  the  urine  of  apparently  
healthy  patients.  Its  prevalence  varies  with  age,  gender,  and  the  
presence  of  genitourinary  abnormalities.  The  prevalence  is  1%  
among  children  under  the  age  of  1  and  school  girls.  It  is  of  0.03%  
for  school  boys  and  men,3%  in  non  pregnant  adult  women  and  5%  
for  pregnant  women.  Screening  and  treatment  for  asymptomatic  
bacteriuria  is  recommended  only for  pregnant  women  ,patients  
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undergoing  transurethral  resection  of  prostate or other  urological  
surgeries,   and  renal  transplant  recepients.  Screening  and  treatment  
is  not  recommended  for  premenopausal,  diabetic  women,  non  
pregnant  women,  persons  with  spinal  cord  injury,  and  catheterized  
patients.  E.coli  is  the  commonest  organism  causing  asymptomatic  
bacteriuria.  Pregnant  women  with  asymptomatic  bacteriuria  are  more  
prone  for  pyelonephritis  and  hypertension.  Preterm  deliveries  and  
low  birth  weight  infants  are  also  common  in  pregnant  women  with  
asymptomatic  bacteriuria  .  These  organisms  possess  lesser  virulence  
characteristics  than  those  causing  symptomatic  infections. 
Acute  cystitis  20 
The  features  of  cystitis  are   
 abrupt  onset  of  micturition  and  urgency 
 dysuria(  i.e)  scalding  pain  in  the  urethra  during  
micturition,suprapubic  pain  during  and  after  
voiding 
 desire  to  pass  urine  after  micturition  due  to  
spasm  of  inflamed  bladder  wall 
 Cloudy  urine  with  an  odour 
 Presence  of  haematuria. 
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  Fever  and  other  signs  of  systemic  illness  are  usually  absent 
because  cystitis  is  a  local  infection. 
Urethritis 
Urethritis  is  a  common  infection  with  symptoms  of  dysuria  
and  frequency.  The  common  causes  of  urethritis  is  Escherichia  coli.  
The    non  specific  urethritis  is  due  to  organisms  such  as  Chlamydia  
trachomatis,  Neisseria  gonorrhea,  Trichomonas  vaginalis  ,  herpes  
simplex  and  cytomegaloviruses. 
Pyelonephritis21,22 
Pyelonephritis  is  a  bacterial  infection  of  the  kidneys  that  
results  from  ascent  of  the  pathogens  from  bladder  to  the  kidneys  
through  the  ureters.The  incidence  is  higher  in  healthy  women  
between  15-29  years  of  age,  followed  by  infants  and  older  persons.  
E.coli  is  responsible  for  80%  of  acute  pyelonephritis  cases.  Other  
causative  organisms  include  Enterobacteriaceae,  Pseudomonas  
aeruginosa,  group  B  streptococci  and  enterococci.  Risk  factors  
include  structural  abnormalities  of  the  urinary  tract,  previous  urinary  
tract  infections,  and  diabetes.  The  clinical  features  are  lower  urinary  
tract  symptoms  (urinaryfrequency,  urgency,  dysuria),  along  with  
fever,  rigors,  nausea,  vomiting,  and  flank  pain.  The  fever  is  high,  
spiking  “picket-fence”  pattern  and  resolves  after  72  hours  of  
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therapy.  In  20-30%  of  patients  pyelonephritis  leads  to  bacteremia.  
Papillary  necrosis  may  occur  in  patients  with  diabetes,  sickle  cell  
disease  and  analgesic  nephropathy.  It  produces  obstruction  and  rise  
in  serum  creatinine  level. 
Emphsematous  pyelonephritis,  a  necrotizing  form  of 
pyelonephritis  with  gas  formation  and  is  seen  in  patients  with  
diabetes  mellitus. 
Xanthogranulomatous  pyelonephritis,  is  a  chronic  infection,  
that  resembles  a  tumour,  and  is  usually  associated  with  obstruction  
and  generally  requires  nephrectomy. 
Acute  urethral  syndrome 
Patients  with  this  syndrome  are  young,  sexually  active  
women,  who  have  cardinal  symptoms  of  dysuria,  frequency  and  
urgency.  They  yield  less  than  105  cfu/ml  (colony  forming  units  per  
ml).90%  of  patients  have  pyuria.(presence  of  ≥8  puscells  per  cubic  
millimeter  on  microscopic  examination  of  uncentrifuged  urine).  
Urethritis,  vaginitis  and  prostatitis  are  the  causes  of  acute  urethral  
syndrome.  Non  specific  urethritis  anaerobic  infection  and  genital  
herpes  account  for  some  of  the  cases.23 
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Catheter  associated  urinary  tract  infections(  CAUTI  ) 
Catheter  associated  urinary  tract  infection  is  defined  as  the  
presence  of  symptoms  and  signs  compatible  with  urinary  tract  
infections  in  a  patient  who  has  been  catheterized  within  the  
previous  48  hours.,  with  no  other  source  of  infection,  along  with  
≥103  cfu/ml  of  urine.24CAUTI  accounts  for  30%  of  nosocomial  
infections  and  is  associated  with  prolonged  hospital  stay.  Long  term  
catheterization,  old  age,  female  sex,  and  diabetes  are  risk  factors  
associated  with  CAUTI.  The  order  of  frequency  of  pathogens  were  
E.coli,  Klebsiella,  Pseudomonas,  Candida,  Enterococcus,  Coagulase  
negative  staphylococcus,  Citrobacter,  and  Proteus  species  .This  can  
be  avoided  by  using  catheters  in  situations,  except  where  there  is  
an  absolute  indication  and  observing  strict  asepsis  during  the  
procedure.25 
Diagnosis 
Detailed  history  and  physical  examination  is  necessary.  In  
case  of  pyelonephritis  imaging  studies  may  be  necessary.  Urine  can  
be  sent  to  the  laboratory  for  analysis  .  Proper  collection  of  urine  is  
very  important  since  urine  specimen  is  much  more  prone  for  
contamination. 
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Collection  of  urine 
Clean  catch  midstream  specimen  :  It  is  the  most  commonly  used    
method  of  urine  specimen  collection.  The  technique  involved  is  
based  on   collecting  urine   aseptically avoiding  the  first  portion  
which  is  likely  to  be  contaminated.  Clean  catch  midstream  urine  
should  be  collected  in  a  sterile,  wide  mouthed,  screw  capped  bottle,  
after  thorough  cleansing  of  external  genitalia  with  soap  and  water.  
Antiseptics  should  not  be  used  for  this  purpose. 
Indwelling  or  Foley’s  catheter:  Urine  is  collected  by  disinfecting  a  
portion  of  the  catheter  tube  with  alcohol,  puncturing  the  tube  with  
a  sterile  needle and  syringe  and  aspirating  the  urine  .Urine  should  
not  be  collected  from  the  collection uro  bag. 
Suprapubic  aspirate  :  Since  urethral  contamination is  avoided 
suprapubic  aspirate  is  preferable.  It  is  usually  performed  in  children  
from  whom  it  is  difficult  to  collect  urine.  In  this  method  skin  
above  the  bladder  is cleaned  with  a  disinfectant   ,a  sterile  needle  
and  syringe  is  introduced  into  the  bladder,  urine is aspirated  and  
placed  in  a  sterile  container.26   
Specimen  transport  :Since  urine  acts as  an  excellent  culture  
medium  for  bacteria  ,  it  must  be  sent  to  the  laboratory  as  soon  as  
it  is  collected  and  should  be  cultured  immediately  .If  this  is  not  
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possible  it  may  be  refrigerated  at  4-6◦C  maximum  for  2  hours  
before  plating  .When  delay  in  delivery  of  more  than  2  hours  is  
anticipated,  boric  acid  preservative(0.1gm/10  ml  )  should  be  added  
to  urine.  Specimen  containing  boric  acid  need  not  be  refrigerated.27  
Other  preservatives  used  are  tartaric  acid,  boric  acid  ethyl  paraben,  
chlorhexidine,  thymol  and  sodium  propionate.  Using  this  
preservatives  urine  can  be  stored  for  upto  24-72  hours  without  
refrigeration.28 
Screening  tests  for  bacteriuria  and  pyuria 
Microscopic  examination: 
Examination  of  an  uncentrifuged  urine  :Detecting  bacteria  in  
uncentifufed  urine  indicates  urinary  tract  infection  .i.e  bacteriuria  in  
excess  of  104  /ml.  Pyuria  can  be  quantified  by  counting  White  
blood  cells  or  estimating  numbers  by  examining  a  drop  of  urine  on  
a  slide.  Alternatively,  an  inverted  microscope  is  used,  in  which  
60µl  of  urine  is  examined  in  a  flat  bottom  well  of  a  microtitration  
plate  and  cell  numbers  calculated  using  a  simple  formula. 
Preparation  and  examination  of  a  wet  preparation:  Aseptically  
transfer  about  10  ml  of  urine  to  a  conical  tube,  centrifuge  at  500-
1000g  for  5  minutes.  Transfer  one  drop  of  well  mixed  sediment  to  
a  slide,  cover  with  a  cover  glass  and  examine  the  preparation  using  
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10x  and  40x  objective.  Report  for  bacteria,  pus  cells,  red  cells,  
casts,  epithelial  cells,  yeast  cell  and  eggs  of  schistostoma  
hematobium. 
Examination  of  the  Gram  stained  preparation.  In  the  examination  
of  the  Gram  stained  preparation  of  the  uncentrifuged  urine  ,presence  
of  at  least  one  organism  per  oil  immersion  field  has  a  sensitivity  
of  94%  and  specificity  of  90%  for  detecting  colony  counts  of  
atleast  105colony  forming  units  per  ml.29 
Tests  for  bacterial  products30:  Griess  nitrite  test  :Nitrite  is  absent  
in  normal  urine.  The  presence  of  nitrite  detectable  by  a  simple  test,  
indicates  the  presence  of  nitrate  reducing  bacteria  in  urine.  This  
was  first  applied  to  urine  by  J.Cruishank  and  J.Moyes  in  1914.31 
Catalase  test  :  On  addition  of  hydrogen  peroxide,  frothing  indicates  
the  presence  of  catalase  .It  is  an  indication  of  bacteriuria  and  
hematuria. 
Triphenyltetrazoliumchloride  :It  is  based  on  the  production  of  
pink  red  precipitate  in  the  reagent  caused  by  the  respiratory  activity  
of  growing  bacteria. 
Dip  slide  culture  methods  :Agar  coated  slides  are  immersed  in  
urine  or  exposed  to  the  stream  of  urine  during  voiding,  incubated,  
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and  growth  estimated  by  colony  counting  or  by  color  change  of  the  
indicators. 
Tests  for  pyuria 
Leucocyte  esterase  test  strip:  This  is  based  on  the  esterase  activity  
of  granulocytes  to  hydrolyse  an  indoxyl  ester  to  free  indoxyl  which  
reacts  with  a  diazonium  salt  to  form  a  violet  dye.  Automatic  test  
strip  reading  is  now  available  to  improve  the  reliability  of  the  
results. 
Leucocyte  counting  by  Rant-Shepherd  method:  J  D  Rant  and   Dr 
W  Shepherd  devised  a  method  of  using  an  inverted  binocular  
microscope  with  a  mechanical  stage  and  plastic  flat  bottomed  
microtitre  wells.  Fixed  volume  of  urine  is  pipetted  out  into  the  tray  
and  observed  microscopically  .From  the  knowledge  of  the  area  of  
the  field  and  depth  of  the  urine  in  the  well  ,the  number  of  
polymorphs  in  the  urine  can  be  estimated.31,32 
Haemophilus,  Gardnerella,  Mycobacteria,  Mycoplasma,  and  
Chlamydia  could  be  the  possible  agents,  if  there  is  presence  of  pus  
cells  without  culture  growth. 
Unacceptable  specimens  :  Foley  catheter  tips,  sediment  from  
centrifuged  urine which  are  inoculated  into  broth ,  urine  stored   for  
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more  than  2  hours   at  room  temperature  or  dried  dip  slides  are  
specimens  unacceptable  for  culture.33 
Urine  Culture   
Urine  culture  is  the  Gold  standard  in  the  diagnosis  of  UTI.11 
Surface  viable  count  by  Miles  and  Misra  method:  An  inoculam  
is  deposited  as  drops  from  a  calibrated  dropping  pipette  with  
different  dilutions  in  separate  plates..Counts  are  made  in  drop  area  
showing  the  largest  number  of  colonies  without  confluence.  The  
total  of  the  counts  give  the  viable  count  per  0.1  ml  of  dilution.  
This  method  is  too  laborious  for  routine  use.34 
Semi-quantitative  culture:  The  methods  used  for  the  semi  
quantitative  culture  are  calibrated  loop  technique  and  the  filter  paper  
dip  strip  method.35   
Calibrated  loop  technique: 
To  evaluate  the  clinical  significance  of  a  positive  urine  
culture  estimation  of  the  number  of  organisms  present  is  essential.  
A  measured  amount  of  urine  is  inoculated  to  each  of  the  
appropriate  media.  Urine  should  be  thoroughly  mixed  before  plating.  
Serial  dilutions  of  urine  is  made  by  mixing  0.1  ml  of  urine  with  
sterile  normal  saline.  A  calibrated  loop  with  a  diameter  of  2mm  or  
4  mm  can  be  used.  The  loop  should  be  made  up  of  metal  or  
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plastic  .A  4mmloop  delivers  0.01  ml  of  urine  and  2mm  loop  
delivers  0.001ml  of  urine.   
Method:  
1. Insert  the  loop  vertically  into  the  urine  to  allow  urine  to  
adhere  to  the  loop 
2. Spread  the  loopful  of  urine  over  the  surface  of  the  agar  
plates 
3. Loop  should  touch  to  the  centre  of  the  plate,  from  which  
the  inoculam  is  spread  in  a  line  across  the  diameter  of  the  
plate. 
4. Without  flaming  or  reentering  urine,  loop  should  be  drawn  
across  the  entire  plate,  crossing  the  first  inoculam  streak  
numerous  times  to  produce  isolated  colonies. 
 
Incubate  the  plates  overnight  at35◦C  . 
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Filter  paper  method:  The  filter  paper  dip  strip  method  of  Leigh  
and  Williams  is  based  on  the  absorption  and  transfer  of  a  fixed  
amount  of  urine  to  a  suitable  plating  agar  medium.  But  growths  are  
often  confluent  and  mixed  .To  obtain  pure  cultures  for  sensitivity  
testing,  it  may  require  further  plating.  Estimate  the  number  of  
viable  bacteria  per  ml  of  urine  from  the  count  of  colonies  on  the  
impression  area  or  the  pattern  of  semi-confluent  or  confluent  
growth. 
 
Choice  of  media 
The  choice  of  media  to  inoculate  varies  with  the  different  
Microbiology  laboratories  .Use  of  5%  sheep  blood  agar  plate  and  a  
MacConkey  agar  plate  allows  detection  of  most  Gram  negative  
bacilli,  Staphylococci,  Streptococci  and  Enterococci.  In  some  
circumstances  enterococci  and  streptococci  may  be  obscured  by  the  
heavy  growth  of  Enterobacteriaceae.  Hence  some  laboratories  add  a  
selective  media  like  Columbia  colistin  nalidixic  acid  agar  or  
phenylethylalcohol  agar  for  Gram  positive  organisms.  Cystine  
lactose  electrolyte  deficient  (CLED)  agar  is  also  used  which  
differentiates  lactose  fermenting  and  non  lactose  fermenting  colonies. 
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MacConkey  agar  This  medium  was  developed  by  Alfred  
Theodore  MacConkey  while  working  as  a  bacteriologist  for  the  
Royal  Commission  on  sewage  disposal.  This  was  the  first  solid  
differential  media.  It  is  primarily  used  in  the  isolation  of  Gram  
negative  bacteria  from  faeces,  urine,  water  and  food.  It  is  a  
selective  and  differential  media,  used  for  the  isolation  of  enteric  
Gram  negative  bacteria.  Gram  negative  bacteria  that  grow  on  
MacConkey  are  differentiated  by  their  ability  to  ferment  lactose.  If  
the  organisms  ferment  lactose  the  production  of  acid  drops  the  pH  
of  the  media,  indicated  by  the  change  of  neutral  red  indicator  to  
pink.  Gram  negative  bacteria  that  grow  on  MacConkey  agar  do  not  
ferment  lactose  and  appear  colourless  on  the  medium. 
Composition  of  MacConkey  agar 
Enzymatic  digest  of  gelatin,  casein,  and  animal  tissue  
provides  vitamins  ,minerals,  nitrogen  and  aminoacids  essential  for  
growth.  Lactose  is  a  carbohydrate  which  provides  carbon  and  
energy.  Sodium  taurocholate  and  crystal  violet  are  the  selective  
agents  inhibiting  Gram  positive  organisms.  Neutral  red  is  a  pH  
indicator    which  is  red  in  colour  at  pH  6.8. 
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Modifications  of  MacConkey  agar   
MacConkey  agar  without  crystal  violet  :Lack  of  crystal  violet  
permits  the  growth  of  Staphlococcus  and  Enterococcus. 
MacConkey  agar  without  sodium  chloride  is  used  to  prevent  
swarming  of  Proteus. 
Blood  agar  : 
In  1919,  James  Brown36  used  a  blood  agar  medium  to  show  
the  haemolytic  properties  of  Streptococcus.  It  is  an  enriched  and  an  
indicator  medium  showing  the  type  of  haemolysis  such  as  
alpha,beta,  and  gamma  haemolysis.  The  medium  is  prepared  by  
adding  sterile  blood  to  sterile  nutrient  agar  that  has  been  melted  
and  cooled  to  50◦C.  Blood  may  be  used  at  a  concentration  varying  
from  5-10%.Either  human  or  animal  blood  can  be  used.  It  is  a  
medium  used  for  the  culture  of  fastidious  organisms  .Sheep  blood  
has  proved  to  be  the  more  versatile  additive.  Incorporation  of  blood  
provides  enrichment  for  growth  and  also  haemolytic  activity.  
Staphylcoccus  aureus    usually  produces  a  golden  yellow  pigment  on  
blood  agar.  Staphylococcus  saprophticus  produces  either  bright  
yellow  or  white  colonies.  Staphylococcus  epidermidis  produces  
white  colony.  Staphylococcus  aureus  is  usually,  but  not  always  
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beta-hemolytic.  Staphylococcus  epidermidis  and  saprophyticus  are  
always  non-hemolytic. 
CLED  agar 
Cystiene  Lactose  Electrolyte  Deficient  Medium 
It  is  used  for  the  isolation  and  differentiation  of  urinary  
pathogens.  An  attempt  to  prevent  swarming  of  Proteus  by  the  use  
of  an  electrolyte-deficient  medium,  by  Sandys  in  1960  led  to  the  
development  of  a  new  medium.  On  subsequent  modification  by  
Mackey  and  Sandys  with  addition  of  cystine  resulted  in  CLED  agar  
media. 
Beef  extract  and  casein  peptone  provide  nitrogen,  vitamins,  
minerals  and  aminoacids  for  growth.  Lactose  is  the  fermentable  
carbohydrate  providing  carbon  and  energy.  L-cystine  is  added  as  a  
growth  supplement.  Bromothymol  blue  is  a  pH  indicator  which  
differentiates  lactose  fermenters  and  non  lactose  fermenters.  
Organisms  which  ferment  lactose  will  change  the  colour  from  green  
to  yellow.  It  has  the  advantage  of  supporting  the  growth  of  
Staphylococci,  Streptococci  and  Candida.37 
Of  late  Chromogenic  media  has  been  introduced  and  
available  which  allows   direct  identification   and  differentiation  of  
uropathogens  on    the  primary  plates  itself.  This  enhances    the  rapid  
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identification  of  the  isolates.  In  1979  Dr.Alain  Rambach  started  the  
work  on  chromogenic  medium.  In  1989  Rambach  agar-  salmonella  
was  discovered.  Chromagar  UTI  is  formulated  on  the  basis  of  the  
work  done  by  Pezzlo,  Wilkie  et  al, Friedman  et  al, Murray  et  al  
and  Merlini  et  al.  This  media  can  be  used  in  place  of  MacConkey  
agar,  for  isolation  and  identification  of  microorganisms.  
Identification  is  done  on  the  basis  of  different  colony  colors  
produced  by  genus  or  species  specific  enzymes  reacting  with  the  
chromogenic  substrate.  The  basal  nutritive  ingredients  are  peptone  
and  glucose.  Addition  of   chromogenic  mixtures  and  other  
substances   have  contributed  to  the  development  of  a  series  of  
media,  specific  for  different  organisms.  Greater  recovery  of  
organisms  and  increased  specificity are  the  benefits  of  these  media.  
Limited  shelf life  and  cost  effectiveness  are  to  be  compared  with 
other  standard  media.38  This  media  acts  both  as  a  selective  medium  
and  a  differential  medium.39 
Enzymes  produced  by  Escherichia  coli,  Enterococcus  species  
and  other  coliform  bacteria  cleave  the  chromogenic  substrates  
incorporated  in  the  medium.  E.coli  produce  pink  colonies  due  to  
the  enzyme  β-D-galactosidase  which  cleaves  the  chromogenic  
substrate.  It  is  further  confirmed  by  spot  indole  test  using  
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dimethylamino  cinnamaldehyde  reagent.  The  enzyme  β  glucosidase,  
produced  by  the  Enterococcus  species  produce  blue  colonies.  The  
ingredients  peptic  digest  of  animal  tissue,  and  casein  hydrolysate  
provide  a  rich  source  of  phenylalanine  and  tryptophan.  Proteus  spp,  
Morganella  spp  and  Providencia  spp  can  be  identified  by  the  
tryptophan  deaminase  activity  ,  appearing  brown  on  addition  of  
ferric  chloride  reagent.  The  Klebsiella  Enterobacter-Serratia  group  of  
species  produce  both  β  glucosidase  and  β  galactosidase  enzymes  
and  the  colonies  appear  predominantly  blue.39 
Interpretation  of  urine  cultures 
Colony  count  on  calibrated  loop  plates:  If  urine  is  undiluted  and  
if  4  mm  loop  is  used  which  delivers  0.01  ml  of  urine  ,  multiply  
the  number  of  colonies  by  100.  Multiply  by  1000  if  1  in  10  
dilution  of  urine  is  used. 
Significant  bacteriuria 
Although  the  greater  part  of  urinary  tract  is  devoid  of  
commensal  flora  ,spontaneously  voided  urine  is  apt  to  be  
contaminated  with  commensal  bacteria  from  the  urethra  and  
perineum  .E.coli  and  Staphylococcus  are  the  commonest  organisms  
to  infect  the  urinary  tract  .They  are  also  the  commensals.  Hence  
proof  of  a  urinary  tract  infection  requires  the  demonstration  that  the  
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pathogens  are  present  in  freshly  voided  urine  in  numbers  greater  
than  those  resulting  from  contamination.   
L  Rantz  and  CS  Keefer  introduced  the  31the  diagnostic  
criteria  of  105organism  per  ml  in  1940  .It  was  substantiated  in  
1957  by  EH  Kass  who  also  demonstrated  the  importance  of  clean  
catch  mid  stream  urine  sample.In  1982,  Stamm  et  al  studied  the  
diagnostic  criteria  in  women  with  acute  symptomatic  lower  urinary  
tract  infections.  The  criteria  of  102  CFU/ml  provided  a  better  
sensitivity  and  specificity.  The  presence  of  pyuria  in  uncentrifuged  
urine  was  considered  as  a  sensitive  adjuant.40 
General  recommendations  for  reporting 
Category1:   
Fewer  than  104  CFU/ml.  Report  as  probable  absence  of  
UTI.(exceptions  are  supra  pubic  puncture,  cystoscopy,  symptomatic  
women,  or  the  presence  of  leukocyturia.) 
Category  2: 
104-105CFU/ml  .If  the  patient  is  asymptomatic  request  a  
second  urine  specimen.  If  the  patient  is  symptomatic  proceed  with  
the  susceptibility  tests.41 
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Category  3:   
More  than  105  CFU  per  ml.  Proceed  with  identification  and  
susceptibility  tests. 
In  addition  to  the  above  mentioned  guidelines,  pure  culture  of  
Staphylococcus,  Enterococci  and  candida  are  significant  regardless  
of  the  number  of  CFUs.  Also  in  mixed  cultures  from  a  Clean  
catch  midstream  urine,  when  there  is  predominance  of  a  single  
organism,  identification  and  susceptibility  testings  are  done  for  that  
organism.42 
Interpretation  of  mixed  cultures 
Specimen  with  3  or  more  uropathgens  :  It  indicates  probable  
contamination.  The  organism  should  not  be  identified  and  ask  for  a  
fresh  Clean  catch  midstream  urine  specimen. 
Specimen  with  1  or  2  significant  uropathogens  :   
Organisms  with  ≥105  CFU  /  ml  should  be  identified  and  
susceptibility  tests  should  be  done. 
Specimen  with  1  or  2  organisms  in  small  numbers  : 
Organisms  with  colony  counts≥102  CFU  /  ml  should  be  
identified  in  acute  urethral  syndrome  or  with  previous  antibiotic  
therapy. 
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Microbiology  of  UTI  :  
In  uncomplicated  cases  the  organisms  isolated  are usually 
Escherichia  coli  or  Staphylococcus  saprophyticus.  In  complicated  
cases  along  with  Enterobacteriaceae,  Gram  positive  organisms  such  
as  Enterococci  are  commonly  encountered.  Polymicrobial  infections  
are  common  in  catheterized  patients.  Pyelonephritis  is   commonly  
caused  by  Escherichia  coli,  Staphylococcus  aureus  and  Proteus  
mirabilis. 
In  nosocomial  infections,  next  to  Escherichia  coli  ,Enterococci  
are  most  commonly  isolated.  Bacteremia  is  usually  associated  with  
urinary  tract  infections  caused  by  Enterococci. 
Prevalence  of  common  organisms  causing  urinary  tract  
infections43 
Organism Community  
acquired  infections 
Hospital  
acquired  infections 
Escherichia  coli 70-80% 50% 
Proteus  mirabilis 10% 1-5% 
Klebsiella 1-5% 5-10% 
Staphylococcus  
saprophyticus 
10-15% 0% 
Staph.epidermidis 1-5% 10-20% 
Enterococci 1-5% 10-20% 
Other  coliforms ˂   1% 5-10% 
Pseudomonas  
aeruginosa 
1-2% 5-10% 
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Treatment  of  UTIs  :10,11,33 
Un  complicated  cystitis:   
Drug  of  choice  is  cotrimoxazole  and  fluroquinolones,  which  
are  usually  given  for  three  days..  During  pregnancy  cotrimoxazole  
and  quinolones  are  contraindicated.  In  such  situations  β-  lactam  
antibiotics  such  as  amoxycillin,  cephalosporins  or  urinary  antiseptics  
such  as  nitrofurantoin  may  be  used. 
Complicated  UTI  :   
Occurs  in  patients  with  structural  and  functional  abnormalities  
of  the  urinary  tract.  The  treatment  should  be  guided  by  urine  
culture  results.The  empirical  therapy  should  be  based  on  the  
previous  culture  data. 
Pyelonephritis  : 
In  uncomplicated  pyelonephritis  ,the  choice  of  oral  therapy  
includes  Ciprofloxacin  and  Cotrimoxazole.  For  parenteral  therapy  
fluroquinolones,  an  aminoglycoside  with  or  without  ampicillin  ,an  
extended  spectrum  cephalosporin  with  or  without  an  aminoglycoside  
or  a  carbapenem  can  be  used.  For  complicated  cases  combination  
of  β  lactam  and  a  β  lactamase  inhibitor  or  imipenem  can  be  used  
depending  on  the  culture  results. 
 
40 
 
Asymptomatic  bacteriuria:  
In  pregnancy  and  in  persons  undergoing  urologic  surgeries  
treatment  should  be  based  on  the  culture  reports. 
Nitrofurantoin  and  methenamine  are  urinary  antiseptics  They  
are  concentrated  in  the  urinary  tract  and  are  active  at  a  lower  pH. 
Prophylaxis 
Vaccines  :  44,45 
Attempts  have  been  made  in  developing  vaccines  against  
infections  caused  by  Escherichia  coli  and  Proteus.  Vaccines  based  
on  single  virulence  factor  or  whole  cell  killed  vaccine  have  been  
tried  in  animal  models,  but  because  of  many  virulence  factors  
associated,  this  is  not  sufficient  to  give  protection. 
An  antibiotic  prophylaxis  is  indicated  in  patients  with  frequent  
UTI 
Mechanism  of  antibiotic  resistance:   
Today  every  class  of  antibiotic  is  associated  with  the  
emergence  of  significant  resistance.  Two  major  factors  are  
associated  with  the  emergence  of  antibiotic  resistance;  evolution  and  
clinical  practices.  Pathogens  evolve  to  develop  resistance  to  survive  
under  stress.  Indiscriminate  use  of  antibiotics  and  poor  clinical  
practices  that  fail  to  incorporate  the  pharmacological  properties  of  
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antimicrobials,  amplify  the  speed  of  development  of  drug  resistance.  
In  Gram  negative  bacteria  the  mechanisms  of  antibiotic  resistance  
are  as  follows: 
Efflux  of  antibiotics  from  bacteria:   
Efflux  pumps  play  a  key  role  in  antibiotic  resistance  and  also  
serve  other  functions  in  bacteria  such  as  uptake  of  essential  
nutrients  and  ions,  excretion  of  metabolic  end  products  and  
deleterious  substances  as  well  as  the  communication  between  cells  
and  the  environment.  This  mechanism  of  resistance  is  a  major  
problem  because  a  single  efflux  pump  can  produce  a  simultaneous  
resistance  to  a  number  of  antibiotics. 
Outer  membrane  permeability:   
The  outer  membrane  of  Gram  negative  bacteria  is  a  barrier  to  
hydrophobic  and  hydrophilic  compounds. The  outer  membrane  acts  
as  a  selective  barrier  by  combining  the  hydrophobic  lipid  layer  with  
pore  forming  proteins  which  have  specific  size  and  exclusion  
properties.  Small  hydrophobic  antibiotics  such  as  beta -lactams,  use  
the  pore  forming  proteins  embedded  in  the  outer  membrane  to  enter  
into  the  bacteria,  while  macrolides  and  other  antibiotics  diffuse  
across  the  lipid  bilayer.  The  existence  of  antibiotic  resistant  strains  
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in    bacteria  due  to  alteration  in  lipid  or  protein  composition  of  the  
outer  membrane  shows  the  importance  of  outer  membrane  barrier . 
Target  modification:   
The  mechanism  is  based  on  alteration  of  bacterial  sites  that  
are  targeted  by  antibiotics  and  thus  preventing  the  antibiotic  from  
binding  to  its  site  of  action.  For  example  fluroquinolone  resistance  
is  attributed  to  mutations  within  the  drug  ̛s target.(DNA  gyrase  and  
topoisomerase). 
Enzymatic  modification  of  the  antibiotic:   
There  are  two  methods   
1) β-lactamases  that  degrade  antibiotics. 
2) chemical  transformation  to  render  the  antibiotic  
inefficient.(macrolide  and  aminoglycoside  modifying  
proteins). 
Acquisition  and  spread  of  antibiotic  resistance  in  bacteria: 
Inherent  resistance:   
Inherent  resistance  in  bacteria  may  be  due  to  lack  of  
transport  system  for  an  antibiotic  or  lack  of  target  to  the  antibiotic  
molecule.  The  outer  membrane  in  Gram  negative  bacteria  acts  as  a  
permeability  barrier. 
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Acquired  resistance:   
All  require  either  modification  of  existing  genetic  material  or  
the  acquisition  of  new  genetic  material  from  another  source.  In  
vertical  transfer  the  resistance  genes  is  transferred  to  bacterial  
progeny  during  DNA  replication.  In  horizontal  or  lateral  gene  
transfer  ,  the  genetic  material  is  contained  in  small  pockets  of  
DNA  and  can  be  transferred  to  different  bacteria  of  same  species  
or  between  different  species.  The  modes  of  transfer  are  
conjugation,  through  plasmids  ,transduction  and  transformation.46   
Βeta  lactam  antibiotics:  β  lactam  antibiotics  are  commonly  
used  for  the  treatment  of  Gram  positive  ,  Gram  negative  and    
anerobic  organisms. 
They  consist  of  four  major  groups:  Penicillins. 
cephalosporins, monobactum  and  carbapenems. 
They  all  have  a  beta  lactum  ring,  which  can  be  hydrolysed  
by  betalactamases.  They  differ  from  each  other  by  additional  rings. 
e.g.,  Thiazolidine  ring  for  penicillin,  cephem  nucleus  for  
cephalosporin,double  ring  for  carbapenem,  and  none  for  
monobactum.At  first  they  inhibit  the  action  of  transpeptidase  
responsible  for  the  completion  of  cell  wall.  Secondly,  they  attach  to  
the  penicillin  binding  proteins  which  causes  cell  lysis. 
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Classification  of  cephalosporins 
First  generation  cephalosporins:  They  include  cefadroxyl,  
cefazolin,  cephalexin,  cephalothin,  cephapirin  and  cephradine. 
Second generation cephalosporins: include  cefaclor, cefamandole, 
cefuroxime, loracarbef,  and  cephamycins  such  as  cefmetazole, 
cefotetan  and  cefoxitin. 
Third generation cephalosporins:  cefaperazone,  cefotaxime, 
ceftazidime, ceftizoxime, ceftriaxone, cefixime, cefpodoxime  and  
cefibuten. 
Fourth  generation  cephalosporins: Cefepime  and  cefpirome. 
Beta  lactamases  are  enzymes  that  catalyze  the  hydrolysis  of  
beta  lactam  ring.  Gram  negative  bacteria  releases  this  enzyme  into  
the  periplasmic  space,  which  gives  individual  protection.  The  genes  
encoding  these  beta lactamases  are  present  on  the  bacterial  
chromosomes.  These  enzymes  are   constitutively  expressed and  
inducible.   The  first  report  of  a  plasmid  encoded  beta  lactamase  
was  reported  from  Greece  in  1965.  Now  there  are  more  than  500  
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beta  lactamases    found.47  Classification  of  betalactamases  are  based  
on  two  approaches,  the  first  one  is  based  on  the  biochemical  and  
functional  characteristics  of  the  enzyme  and  the  second  approach  is  
based  on  the  molecular  structure  of  the  enzyme. 
Evolution  of  functional  classification  of  βlactamases 
Initially  in  1968,  Sawai  et  al  used  cephalosporins  vs  
penicillins  as  substrates,  which  was  modified  by  Richmond  and  
Sykes  in  1973,  by  expanded  substrate  profile.   
Sykes  and  Mathew  in  1976,  differentiated  plasma  mediated  β  
lactamases  on  the  basis  of  isoelectric  focusing,  which  was  modified  
in  1981,  by  Mitsuhachi  and  Inove  who  added  cefuroxime  
hydrolyzing  β  lactamases  category.  Bush  expanded  substrate  profile  
reaction  with  EDTA  (1989)  and  correlated  between  functional  and  
molecular  classification.   
Finally,  in  1995,  Bush  Jacoby  and  Medeiros  expanded  the  
scheme  using  biochemical  properties,  molecular  structure  and  
nucleotide  sequences. 
Molecular  classification;   
It  is  based  on  the  nucleotide  and  aminoacid  sequences  in  
these  enzymes.  Accordingly  A-D  four  classes  are  recognized.   The  
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action  of  Class  A,D and C  are  based  on  serine based  mechanism   
and  the  action  of  class  B  or  metallo  βlactamases  are  based  on  zinc. 
Bush-Jacoby  –Medeiros  functional  classification  with  correlation  
to  the  Ambler  molecular  classification48,49 
Group  1:  Cephalosporinases:  , they are  not  inhibited  by  
clavulanic  acid. Corresponds  to Molecular  class  C 
Group  2a  :  Penicillanase:  Molecular  class  A,  inactivating  
penicillns  and  inhibited  by  clavulinic  acid, 
Group  2b:  Broad  spectrum:  Molecular  classA,  capable  of  
inactivating  penicillins  and  cephalosporins;  also  inhibited  by  
clavulanic  acid. 
Group  2be:  Extended  spectrum:molecular  class  A,  capable  of  
inactivating  monobactems  and   third  generation  cephalosporins  but 
inhibited  by  clavulanic  acid. 
Group  2br:Inhibitor  resistant,  Molecular  class  A  –diminished  
inhibition  by  clavulanic  acid. 
Group  2c:Carbenicillinase  Molecular  class  A,  inactivate  
carbenicillin, with  some  effect  on  cloxacillin  and  inhibited  by  
clavulanic  acid. 
Group2d:Cloxacillinase  Molecular  class  A  &D,  inactivate  
cloxacillin, poorly  inhibited  by  clavulanic  acid. 
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Group2e:  Cephalosporinase,Molecular  class  A,hydrolyse  
monobactams,inhibited  by  clavulanic  acid. 
Group  2f:  Carbapenemase  Molecular  class  A  ,serine  based  
carbapenemases. 
Group  3:  Metalloenzyme,  Molecular  class  B  ,not  inhibited  by  
clavulanic  acid,  able  to  hydrolyse  penicillins,  cephalosporins  and  
carbapenems,  act  by  the  metal  ion  zinc. 
Group  4:Penicillinase  ,no  molecular  class,  inhibited  by  
clavulanic  acid 
Beta  lactamase  inhibitors  :   
These  compounds  resemble  beta  lactam  antibiotics.  They  can  
bind  to  beta  lactam  antibiotics  protecting  them  from  destruction  and  
serve  as  suicide  bombers  utilizing  all  enzymes.  These  compounds  
have  weak  anti  bacterial  activity  but  are  potent  inhibitors  of  many  
plasmid  encoded  and  some  chromosomal  beta  lactamases.  The  
important  beta  lactamase  inhibitors  are  clavulanic  acid,  tazobactum  
and  sulbactum.   
Clavulanic  acid  shows  low  level  of  antibacterial  action  but  
when  combined  with  beta  lactam  antibiotics  it  potentiates  the  beta  
lactam  antibiotics. 
Sulbactam  has  broader  spectrum  of  inhibition  but  less  potent. 
Tazobactam  is  as  potent  as  clavulanic  acid. 
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Extended  spectrum  betalactamases: 
Extended  spectrum  beta  lactamases  are  enzymes  capable  of  
hydrolyzing  third  and  fourth  generation  cephalosporins  and  
monobactams,  but  inactive  against  cephamycins  and  imipenem.  They  
are  inhibited  by  betalactam  inhibitors  such  as  clavulanic  
acid,sulbactam  and  tazobactum.50,51The  ESBLs  have  amino acid  
serine  at  their  active  site  and  they  attack  amide  bond  in  the  lactam  
ring  of  these beta lactam  antibiotics,  causing  subsequent  lysis.  They  
belong  to  Bush-Jacoby-Medeiros  group  2be,  2d  and  Ambler  class  
A. 
History  and  evolution 
The  first  plasmid  mediated  beta  lactamase  TEM-1  was  
described  in  1960.52In  early  years  the  most  common  beta  lactamases  
were  TEM1,2  andSHV1  varities.  In  1983,  the  first  mutant  of  SHV-
1  is  called  SHV-2  in  a  Klebsiella.pneumoniae  strain  was  reported  
from  Germany. It   was  capable  of  hydrolyzing  oximinocephalosporins 
.  These  extended  spectrum  beta  lactamases  differ  from  the  parent  
enzyme  by  aminoacid  substitution  .  The  pressure  exerted  by  the  use  
of  expanded  spectrum  beta  lactam  antibiotics  ,resulted  in  the  
development  of  newer  TEM  and  SHV  varieties. 
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The  type  of  ESBLs  are  TEM,  SHV,  CTX-M,  OXA,  Amp  C  
but  majority  are  derived  from  TEM  or  SHV  enzymes.  These  
enzymes  are  commonly  found  in  E.coli  and  Klebsiella  pneumoniae. 
Sometimes  more  than  one  gene  may  be  present  in  the  same  
organism.53 
Prevalence 
Prevalence  of  ESBLs  vary  in  different  countries  and  in  
different  areas.  In  India  the  prevalence  varies  from  8  to  80%.54The  
prevalence  of  TEM  and  SHV  are  56%  and  60%  respectively. 
Gene  encoding  ESBL 
TEM:   
TEM-1  enzyme  was  first  reported  from  E.coli  in  1965  and  
now  it  is  the  commonest  betalactamase  found  in  Enterobacteriaceae.  
The  name  TEM  is  derived  from  Temoniera  ,  a  patient  from  Greece  
from  whom  the  strain  was  isolated.  Based  on  the  combination  of  
different  aminoacid  changes  ,currently  195  TEM  type  enzymes  have  
been  found. 
SHV  :   
The  name  SHV  denotes  for  sulfhydryl  variable.  About  68%  
of  aminoacid  is  shared  with  TEM-1  .SHV  -1  is  most  commonly  
found  in  Klebsiella  pneumoniae.  ESBLs  in  this  family  have  amino  
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acid  changes  at  238  positions.  There  are  about  60  SHV  variants  are  
known.  SHV-5  was  found  to  be  responsible  for  outbreaks  of  
nosocomial  infections  in  several  countries. 
CTX-M  :   
CTX-M  beta  lactamases  were  first  isolated  from  Munich  in  
Japan  in  1986.E.coli  producing  CTX-M  have  emerged  as  an  
important  cause  of  community  onset  urinary  tract  infections.  These  
enzymes  have   greater  activity  against  cefotaxime.  Change  at  236  
position  enhances  resistance  to  cefotaxime  and  change  at  102  
position  enhances  resistance  to  ceftazidime.  There  are  about  80  
CTX-M  enzymes  which  are  divided  into  5  clusters  on  the  basis  of  
amino  acid  sequence.55  CTX-M  producing  Escherichia  coli  are  
emerging  as  an  important  pathogen  causing  community  onset  and  
hospital  acquired  infections. 
In  India  CTX-M  -15  beta  lactamase,  is  the  most  prevalent.  
The  bowel  provides  a  rich  environment  for  genetic  exchange  
between  commensal  enterobacteriaceae.  Conditions  such  as  
overcrowding,  poor  sanitation  and  inappropriate  use  of  antibiotics  
contribute  to  the  widespread  prevalence  of  CTX-M-  15  beta  
lactamases.56  Some  organisms  may  harbor  more  than  one  type  of  
ESBLs  which  may  alter  the  antibiotic  resistance  phenotype. 
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Other  beta  lactamases  :  OXA  beta  lactamases,  PER,  VEB,  
GES   
Inhibitor  resistant  beta  lactamases  or  Amp  C  beta  lactamases 
These  beta  lactamases  are  also  derived  from  TEM  and  SHV  
type  enzymes  but  they  differ  from  ESBL  s.  They  are  not  inhibited  
by  beta  lactamase  inhibitors.  There  are  about  19  inhibitor  resistant  
TEM  beta  lactamases.  They  are  present  on  the  chromosome  of  
Gram  negative  bacteria  such  as   Serratia , Citrobacter and  
Enterobacter. 
Carbapenamases: 
They  are   beta  lactamases  that  are  active   against  the  
oxyimino  cephalosporins ,  cephamycins   and  also  against  
carbapenems. 
Organisms  producing  ESBLs  :   
Eschrichia  coli  ,Klebsiella  pneumonia,  Proteus  spp,  
Enterobacter,Citrobacter,  and  Pseudomonas 
Risk  factors  associated  with  ESBL  production65 
1. Prolonged  stay  in  intensive  care  units. 
2. Poor  nutritional  status. 
3. Severe  illness. 
52 
 
4. High  rate  use  of  ceftazidime  and  other  third  generation  
cephalosporins. 
5. Long  term  use  of  antibiotics. 
6. Use  of  cental  venous  lines,urinary  catheters,  endotracheal  
tubes,arterial  lines,nasogastric  tubes. 
7. Hemodialysis 
8. Administration  of  total  parenteral  nutrition. 
9. Decubitus  ulcers. 
Laboratory  methods  of  identification  of  extended  spectrum  beta  
lactamases 
1.Phenotypic  methods  
2.  Genotypic  methods: 
Phenotypic  methods  are  commonly  performed  by  the  
laboratories  because  they  are  easy  to  perform  and  cost  effective  
also.  These  tests  depend  on  detecting  synergy  between  clavulanic  
acid  and  the  indicator  cephalosporins. 
Screening  tests   
The  current  Clinical  and  laboratory  standard  institute  
guidelines  for  detection  of  extended  spectrum  beta  lactamases  in  
Klebsiella  spp.  and  E.  coli  includes  an  initial  screening  test  with  
any  two  of  the  following  beta  lactam  antibiotics  :  cefpodoxime  ,  
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ceftazidime,  aztreonam,  cefotaxime  or  ceftriaxone.  The  use  of  more  
than  one  of  the  five  beta  lactam  antibiotics  will  improve  the  
sensitivity  of  detection.  Cefpodoxime  and  ceftazidime  show  the  
highest  sensitivity  for  ESBL  detection.  There  is  also  a  possibility  of  
missing  some  strains  if  the  inoculum  is  very  low. 
Disc  diffusion  method 
According  to  the  CLSI  guidelines  ,isolates  showing  inhibition  
zone  size  of  the  test  results  as  follows 
 
Screening  by  dilution  methods:  Ceftazidime,  aztreonam,  
cefotaxime,  or  ceftriaxone  can  be  used  at  a  screening  concentration  
of  1µg/ml.  Growth  at  this  screening  antibiotic  concentration  is  
suspicious  of  ESBL  production  and  an  indication  for  the  organisms  
to  be  tested  by  phenotypic  confirmatory  methods. 
Zone  of  inhibition  size  in  disc  
diffusion  method 
MIC  break  point  by  broth  
dilution  method 
Cefpodoxime(10µg)  ≤17  mm Cefpodoxime  ≥4  µg/ml 
Ceftazidime  (  30µg)  ≤  22  mm Ceftazidime  ≥  1µg/ml 
Ceftriaxone  (  30µg)  ≤  25  mm Ceftriaxone  ≥  1µg/ml 
Cefotaxime  (  30µg)  ≤  27  mm Cefotaxime  ≥1µg/ml 
Aztreonam  (  30µg)  ≤  27  mm  
54 
 
For  cefpodoxime  MIC  ˃2  µg/ml  is  used  as  a  criteria  to  
perform  phenotypic  confirmatory  tests. 
Phenotypic  confirmatory  tests: 
Double-disk  synergy  test  :   
This  method  of  phenotypic  confirmation  was  proposed  in  
1980  explained  by  Jarlier  et  al  .Organism  to  be  tested  is  placed  on  
the  Mueller  –Hinton  agar.  An  antibiotic  disc  containing  one  of  the    
beta  lactam  antibiotics  is  placed  30 -15 mm  apart  (  centre  to  centre  
)  from  amoxicillin-  clavulanic  acid  disc.  Following  overnight  
incubation  in  air  at  37◦c  ,the  discs  are  read.  Enhancement  of  zone  
of  inhibition  of  the   beta  lactam antibiotic  caused  by  synergy  of  
clavulanate  indicates  a  positive  result.  Sensitivity  is  increased  by  
reducing  the  distance  between  the  discs  to  20  mm.  Addition  of  
clavulanate  to  the  Muller-Hinton  agar  increases  the  sensitivity.57 
Disc  strength  :  Cephalosporin  (  3rd  generation  )    -  30µg/disc. 
Coamoxyclav  -  20µg  amoxicillin+10µg  clavulanic  acid 
Combined  disc  method  :   
In  this  test  the  organism  to  be  tested  is  swabbed  on  a  plate  
of  Muller  –Hinton  agar.  Ceftazidime10µg  disc  alone  and  in  
combination  with  clavulanic  acid  (  ceftazidime  30µg  +clavulanic  
acid  10µg)  are  placed  20  mm  apart.  Similarly  cefotaxime  30µg  and  
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cefotaxime  30µg+  clavulanic  acid  10µg  are  also  placed  20  mm  
apart.  The  plates  are  incubated  overnight  aerobically  at  37◦c.  An  
increase  of  ≥  5mm  of  the  zone  diameter  of  either  of  the  
antimicrobial  agent  which  are  tested  in  combination  with  clavulanic  
acid  compared  to  that  of  the  individual  discs  alone  are  interpreted  
as  positive  for  ESBL  producers.  Escherichia  coli  ATCC  25922  is  
the  Control  strain  to  validate  the  susceptibility  test.  58 
Vitek  ESBL  cards: 
The  Vitek  ESBL  test  utilizes  ceftazidime  and  cefotaxime  (0.5  
µg/ml) discs  alone  and  these  discs  combined   with  clavulanic  acid  
(0.4  µg/ml).  Once  the  growth  control  well  reached  a  set  threshold,  
automated  analysis  of  the  wells  are  performed.  A  predetermined  
reduction  in  the  growth  of  cephalosporin  wells  containing  clavulanic  
acid,  compared  with  the  level  of  growth  in  the  wells  with  the  
cephalosporin  alone  ,indicates  a  positive  result.59 
BD  Phonex  automated  microbiology  system 
Becton  Dickinson  Biosciences  found  out  BD  phoenix  
system.This    test  has  a  short  incubation  period.  The  principle  of  
this  test  is  the  comparison  of    the  growth  response  to  cefpodoxime,  
ceftazidime,  ceftriaxone  and  cefotoxime  with  or  without  clavulanate  
.  Results  are  available  within  6  hours. 
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The  E  test  method  (Epsilometer  test) 
It  is  a  plastic  drug-impregnated  strip,  one  end  of  which  
generates  a  stable  concentration  gradient  of  cephalosporin,(  i.e,  
ceftazidime,  cefoaxime,  cefepime)  and  the  remaining  end  of  which  
generates  a  gradient  of  cephalosporin  plus  clavulanate  in    a  
constant  concentration.  The  MIC  ratio  of  cephalosporin  alone/  
cephalosporin  plus  clavulanate  MIC  ≥  8  indicates  ESBL  positive  
strains..For  Enterobacter  species  cefepime/clavulanate  E  strip  is  
preferred.66   
Agar  supplemented  with  clavulanate: 
In  this  method  Mueller  –Hinton  agar  is  supplemented  with  
4µg/ml  of  clavulanate.Antibiotic  discs  containing  the  beta  lactam  
antibiotics  are  placed  on  this  agar  and  the  agar  without  clavulanate.  
A  difference  of  ≥  10  mm  in  the  width  of  the  zone  diameter  of  the  
discs  on  the  two  media  is  considered  positive  for  ESBL  production.  
The  clavulanate  containing  agar  has  to  be  freshly  prepared,  as  the  
potency  of  clavulanate  decreases  after  72  hours. 
Disc  replacement  method  : 
In  this  method  three  amoxicillin/clavulanate  discs  are  placed  
on  a  Mueller-Hinton  agar  which  is   inoculated  with  the  test  
organism.  After  1  hour  these  discs  are  taken  away  and  are  replaced  
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by  discs  containing  cefotaxime,  ceftazidime  and  aztreonam  on  the  
same  spot.  Control  discs  of  these  drugs  are  placed  30  mm  from  
these  sites.  An  increase  in  the  zone  size  of  ≥  5  mm  in  the  discs  
which  are  used  for  the  replacement  of  amoxicillin/clavulanate  discs  
compared  to  the  control  discs  indicate  ESBL  production. 
Three  dimensional  test  : 
This  test  developed  by  Thomson,  gives  the  phenotypic  
evidence  of  ESBL  induced  inactivation  of  the  antibiotics.  In  this  
test  it  is  not  necessary  to  demonstrate  the  inactivation  of  beta  
lactamase  by  the  beta  lactamase  inhibitor.  Here  the  surface of  the  
agar   is  inoculated  with  the  test  organism   by  standard  methods  for  
disk  diffusion  testing.  A  circular  hole  is  cut  in  the  agar.  This  hole  
is  filled  with  heavy  inoculam  of  the  test  organism.  Beta  lactam  
antibiotics  are  placed  on  the  agar  3mm  outside  the  hole.  A  
distortion  of  the  zone  size  at  the  point  of  cut  indicates  ESBL.47,60 
Phenotypic  ESBL  confirmation  tests    are  based  on  the  in  
vitro  inhibition  of  these  enzymes  by  clavulanic  acid.  These  tests  are  
applicable  to  Enterobacteriaceae  such  as  Klebsiella,  Escherichia  coli  
and  Proteus  mirabilis  which  have  little  or  no  chromosomal  activity  
β  lactamase  activity.  False  negative  results  can  be  obtained  in  
strains  that  coproduce  an  inducible  or  plasmid  mediated  Amp  C  
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beta  lactamase  .  Amp  C  enzymes  may  be  induced  by  clavulanate  
and  may  then  attack  cephalosporins  masking  synergy  which  is  due  
to  inhibition  of  extended  spectrum  beta  lactamases. 
False  positive  results  can  be  obtained  using  inhibitor  based  
ESBL  detection  tests  in  isolates  which  have  hyperproducing  
chromosomal  beta  lactamases. 
The  phenotypic  detection  of  these  enzymes  in  organisms  such  
as  Enterobacter  and  Citrobacter  remains  a  problematic  and  
controversial  issue.  The  reason  for  this  that  the  clavulanate  effect  
present  in  ESBL  producing  organisms  is  not  always  present  in  
these  species. 
Genotypic  detection  61:   
Many  of  the  research  laboratories  use  genotypic  methods  for  
the  identification  of  the  specific  genes  responsible  for  the  
production  of  ESBLs.  They  also  have  the  ability  to  detect  ESBLs  
which  are  not  detected  by  phenotypic  methods.  They  also  have  the  
advantage  that  they  can  be  done  directly  on  clinical  specimens  
without  culturing  bacteria,  with  subsequent  reduction  of  the  
turnaround  time. 
The  molecular  methods  in  use  are  DNA  probes,  Polymerase  
chain  reaction,  Restriction  fragment  length  polymorphism,  Single  
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strand    conformational  polymorphism  and  Ligase  chain  reaction.  
Most  of  them  are  specific  for  gene  family  and  detects  TEM  and  
SHV  variants.  Among  these  nucleotide  sequencing  is  a  gold  
standard,  since  it  is  capable  of  detecting  all  variants. 
Treatment 
The  plasmid  having  the  genes  encoding for ESBLs  also  carry  
genes  which  encodes  resistance  to  aminoglycosides  and  
cotrimoxazole. 
Porin  loss  was  observed  in  strains  producing  ESBLs  which  
leads  to  quinolone  resistance.  But  for  urinary  tract  infections  
quinolones  can  be  prescribed  if  there  is  in  vitro  susceptibility.   
β  lactam/  β  lactamase  inhibitor  combinations  are  active  
against  organisms  possessing  a  single  ESBL  only.  Additionaly  
ESBL  producing  organisms  may  harbor  parent  enzymes(TEM-1  or  
SHV-1)  .Hyper  production  of  these  enzymes  and  porin  loss  may  
contribute  to  reduction  in  the  activity  of  beta  lactamase  inhibitors.  
Hence  β  lactam  /β  lactamase  inhibitor  combinations  are  not  
regarded  as  first  line  therapy  for  serious  infections  with  ESBL  
producing  organisms.  But  for  urinary  tract  infections  it  can  be  a  
second  line  therapy. 
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Fosfomycin  and  Nitrofurantoin  are  the  treatment  of  choice,  for  
uncomplicated  cystitis.62,63 
Cefepime  resistance  is  seen  in  strains  producing  CTX-M  type  
ESBLs.  Hence  cefepime  ,  if  at  all  used  for  therapy  should  be  used  
in  high  dosage. 
Carbapenems  have  the  most  consistent  activity  against  ESBL  
producing  organisms.  Hence  should  be  regarded  as  the  drugs  of  
choice  for  serious  infections  with  ESBL  producing  organisms. 
  
  
 
 
 
 
 
 
 
 
 
 
 
MATERIALS & METHODS 
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MATERIALS  AND  METHODS 
This  study  on , “ Isolation  and  characterisation  of  uropathogens  
with  conventional  and  chromogenic  media  and  detection  of  extended  
spectrum  beta  lactamases.” was  conducted  in  the  Department  of  
Microbiology  Coimbatore  Medical  College  Hospital. 
Study Period : August  2013 -  July  2014 
Type  of  study : Prospective . 
Approval  from  the  ethical  committee  was  obtained  prior  to  
the  conduct  of  the  study. 
During  the  study  period,   about  422  urine  samples  from  
inpatients  and  outpatients  of  various  departments   such as   Medicine,  
Paediatrics, Surgery, Urology ,Nephrology and  Obstetrics  and  
Gynaecology   were  collected  and  processed.   
Inclusion criteria  : 
1. Urine  samples  collected  aseptically  from  the inpatients and out 
patients.   
2. Patients  with  history  of  UTI s such  as fever, abdominal pain,  
frequency and urgency in urination 
Exclusion criteria : 
1. Febrile  conditions  other  than  the  urinary tract infections. 
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2. Any  deviation  in  collection  of  urine  samples,  without  proper  
aseptic  precautions.   
For  all  the  patients  detailed  clinical  history,  symptoms ,  signs,  
any other   investigations   regarding   urinary  tract  infection ,  
history  of  antibiotic  intake, and previous  surgeries   were  taken  
according  to  the  datas  given  in  the worksheet.  The  name  age,  
sex,  address,  occupation,  date  of  admission, and  inpatient  
number  were  noted.  Complete  systemic  examination  of  the  
patient  was  done. 
Collection  of  urine  specimens:  
As  per  the  CLSI  guidelines GP-16 A3, for urinalysis  Clean   
widebore  container  with a capacity  of  about  50  ml  was  used.  The  
containers  were  sterile  and  leak proof  to  avoid  spillage. 
Clean  catch  midstream  urine29   
Females  were  given  instructions  regarding  the  collection  of  
urine. The  periurethral  area  and  perineum  were  first  cleaned  with  
gauze  pads  saturated  with  soap  water  using  a  forward  to  back  
motion. This  was  followed  by  a rinse  using  sterile  saline  or  water. It  
was  advised  to  held  the  labia  apart  during  voiding.  First  few  
milliliters  of  urine  were  passed  in  the  toilet  or  bedpan  and  the  mid 
stream  urine  was   collected  in a sterile  wide  mouthed  container. 
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For  men  simple  cleaning  of  the  urethral  meatus  was  advised. 
Mid  stream  urine  sample was  collected  in  a  wide  mouthed sterile  
container.  
Collection  of  samples  from  indwelling  catheters 
Urine  samples  were  collected  from  an  indwelling  catheter  using  
a no 28 needle  and  a syringe. The  area  where  the  needle  puncture  to  
be  done  was  disinfected. Urine  was  aspirated  through  the  soft  
rubber  connector  between  the  catheter  and  the  connecting  tubing It  
is  advisible  not  to  collect  urine  from  catheter  bags. 
Transport  of  urine  specimens 
Urine  specimens  were  sent  to  the  laboratory  without  any  delay  
and  processed  within  two  hours. 
Macroscopic  examination  of  the  urine :  
The  color  and  presence  of  turbidty  were  examined. 
Screening  tests  for  bacterial  products  and  pyuria  were  done  by  
reagent impregnated  dipstick method. 
SD Urocolor  test  strips  for  urinalysis  were  used. These  were  
plastic  strips  to  which  were  attached  several  separate  reagent  areas. 
They  provide  tests  for  blood, bilirubin, urobilinogen, ketone,  protein,  
nitrite, glucose  pH,  specific gravity,  leucocytes  and  ascorbic  acid  in  
urine.71 
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Principle :  
Nitrite  One  test  strip  contains p-arsanilic acid, 1, 2, 3, 4 
tetrahydrobenzoquinolin-3-ol. The  test  is  based  on  the  diazotization  
reaction  of  nitrite  with  an  aromatic  amine  to  produce  a diazonium  
salt. It  is followed  by  an  azo coupling  reaction  of  this  diazonium  salt 
with  an  aromatic  compound  on  the  reaction  membrane. The  azo  dye 
produced  causes a color  change  from  white  to  pink. Positive  reaction  
reveals  the  presence  of  nitrite  and  hence  indicates  nitrite  forming  
bacteria. Greater  concentration  of  ascorbic  acid  in  urine  may  cause  a 
false  negative  reaction. 
Leucocyte   One  strip  contains  derived  phenylpyrrole, 
diazonium  salt. The  leucocytes  contain  esterases  that  catalyze  the  
hydrolysis  of  the  derived  pyrrole  aminoacid  ester  to  liberate  3-
hydroxy-5-phenyl pyrrole. This  pyrrole    reacts  with a  diazonium  salt  
to  produce  a  red  purple  product. 
Procedure   Mix well  the  collected  urine,  take the  strip  from  
the  bottle, immerse  test  areas of  the  strips  in  urine  and  remove  
immediately. Place  the  strips  on  a  gauze  for  1-2  seconds  to  remove  
excess  urine. Hold  the  strip  in a horizontal position  and  compare  the  
test  areas  to  corresponding  color chart  on  the  bottle  label  .Read  the  
results  at  sixty  seconds. 
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Chromogenic  agar   was  prepared  inhouse  with  the  readymade  
dehydrated  powder.It  is  a HiCrome UTI agar,modified bought  from  
Himedia. Composition  and  ingredients  are  given  in  the  appendix -1. 
Directions  for  preparation 
Suspend  55.44 grams  in  1000ml  distilled  water.  Heat  to  
boiling  to  dissolve  the  medium  completely. Sterilize  by  autoclaving  
at  15 lbs  pressure (121◦C) for 15  minutes.  Cool  to  45-50◦C and  pour  
into  sterile  petri  dishes. The  pH of  the  medium  is  between  7-7.4. 
The  media  was  stored  at  2-8◦C for  upto  two  weeks. 
Each  batch  of  media  were  tested  for  the  growth  of  the 
following  organisms.  Staphlococcus  aureus ATCC 25923,  Escherichia 
coli ATCC 13883,  Klebsiella  pneumonia ATCC 13883, Enterococcus  
faecalis ATCC29212, Pseudomonas aeruginosa ATCC 27853, and 
Proteus  mirabilis  ATCC12453 . The  characteristic  growth  and  colony  
colour  which  were  observed  after  incubation  at  37◦C  for  24  hours  
seem  to  match  with  the  manufacturer’s instructions. 
Blood  agar  and  MacConkey  agar  were  prepared  inhouse  
according  to  manufacturer’s instructions. 
Culture  of  the  specimen : Fresh  specimen (uncentrifuged  urine) were  
inoculated  directly  on  blood  agar, MacConkey  agar and  chromogenic  
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agar   plates  and  incubated  overnight  at  37◦c .Plates  were read  on  the  
next day. 
2mm  or  4  mm  loops were  used  and  quadrant  steaking  method  
was  followed. 
Chromogenic agar  plates  were  read  after  24  hours .Presumptive  
identification  of  the  organisms  were  made  according  to  the  colony  
color  and  typical  morphology. 
Organisms Colony  color  and  appearance 
Eschrichia coli Small purple or pink 
Klebsiella Mucoid metallic blue 
Enterococcus Dry,tiny blue 
Proteus Pale brown 
Pseudononas Green 
Citrobacter Metallic blue 
Staphylococcus aureus Small colourless to golden 
yellow colonies 
Streptococcus Small translucent  opaque 
CoNS Colorless small differentiated 
Candida Creamy wet convex 
Acinetobacter Non transparent ,cream, white 
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Confirmation  of  E.coli  was  done  by  performing  spot  indole   
test  using  DMACA  reagent.  (Dimethyl amino  cinnamaldehyde).  
Spot indole  test  :  Procedure: 
Moisten  a  piece  of  Whatman’s  no 3  filter  paper  with  a few 
drops  of  the  reagent.  Remove  isolated  colony  from  the  plate, with a  
wooden stick  and  smear  it  on  to  the  moistened  filter  paper. Observe  
blue  color  within  two  minutes. It  indicates  positive  reaction.67 
TDA reagent  : This  was  done  to  identify  Proteus  organisms. The  
reagent  is  a  ferric  chloride  solution  which  when  applied  on the  
colony  growth  produces  a brownish  discolouration  around  the  
organisms. Positive  reaction  indicates  tryptophan  deaminase  activity. 
Colonies  from  blood  agar  plate  and  MacConkey  agar  plates  
were subjected  to biochemical  reactions. These  organisms  were  
compared  with   the  isolates  identified  from  chromogenic  agar. 
Colony  count  and  interpretation:  
 We  used  4 mm  loop   to  inoculate  and  streak  the  plates.  This 
loop  will  carry  about  0.01  ml  of  urine.  So  the  colonies  that  appear  
on  the  plates  were  multiplied  by  100.  
Interpretation :   
 According  to  Kass  concept  significant  bacteriuria  indicates 
Colony  count  greater  than  100000   in  a  single  growth. 
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Colony  count   between  1000-100000 indicates  doubtful  growth. 
Colony  count  less  than  1000 indicates  insignificant  growth. 
In  mixed  growth,  the  organism  showing  colony  count  greater  
than  100000 was  considered  significant  and  processed. 
 
Even  few  colonies if present,   from  Staphylococcus  aureus  
were  processed. 
Gram  positive  organisms  were  processed  from  blood  agar  
plate. Gram  negative  organisms  were  processed  from  MacConkey  
agar  plate. 
Gram  staining, motility, biochemical  reactions  like  catalase, 
coagulase,   oxidase,  indole, Kligler Iron  agar,  citrate ,  and  urease  
tests were  done. 
Tube  coagulase  test 
0.5  ml  of plasma was  taken  in  a  sterile  tube. Few  colonies  
were  emulsified  into  the  tube. The  tube  was  incubated  at  35◦C for  4  
hours  and observed  for  clot  formation  by  gently  tilting  the  tube.  If  
there  was  no  clot  formation  at  that  time  ,reincubate  at  room  
temperature  and  read  after  18  hours. 
Positive  control –Staphylococcus  aureus 
Negative  control- Staphylococcus epidermidis  
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Indole  test 68: 
Principle:  This  is  the  test  to  determine  the  ability  of  an  organism  
to  split  indole  from  tryptophane  molecule. Tryptophan  present  in  
peptones  of  the  culture  media  are  acted  upon  by  the  enzyme  
tryptophanase  and  converted  into  indole,  pyruvic acid  and  ammonia.  
Indole  reacts  with  aldehydes  to  produce  coloured  product. 
Ehrlich’s indole  test:   
Procedure : 1 ml  of  xylene  was  added  to  a  24  to  48  hour  
incubated  broth  culture.  Shaked  well ,  and  allowed  to  stand  for  few  
minutes. Ehrlich  reagent  was  added. 
Interpretation :  The  development  of  bright  red  coloured  ring   at the  
interface  of  the  medium  and  alcoholic  layer  within  few  seconds  
was  indicative  of    positive  reaction. This  test  was  most  useful  in  
separating  Escherichia  coli (positive) from  Klebsiella-Enterobacter-
Hafnia-Serratia  group (mostly  negative ). 
 
Citrate  utilization:  Principle :   The  ability  of  an  organism  to  
utilize  citrate  as  the  sole  source  of  carbon  is  used  in  this  test. The  
utilization  of  citrate  was  indicated  by  the    production  of  alkaline  
byproducts  resulting  in  color  change  in  the  indicator. 
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Simmons citrate  medium:   
Procedure  :  A  well  isolated colony  from  the  surface  of the plate  
was  picked  up  and  inoculated  on  the  slant  surface  of  the  citrate  
agar  slope.  The  tube  was  incubated  at  35◦C for  24-48  hours. 
Interpretation :  Positive  test  was  detected  by  the  growth 
/development  of  deep  blue  color.  Each  new  batch  of  medium  was 
tested  with  a  positive  and  negative  reacting  organisms .Positive 
control-Enterobacter  aerogenes. Negative  control:  Escherichia  coli. 
Urease  test : Principle : This  test  was  used  to  determine  the  ability  
of  the  organism  to  split  urea,  forming  two  molecules  of  ammonia  
by  the  action  of  the  enzyme  urease  with  resulting  alkalinity. 
Media  used:  Christensen’s urea  agar Procedure: The  surface  of  the  
agar  slant  was  streaked  with  a  drop  of  4-6 hour  growth  of 
bacterium  in  broth.  Media  were  incubated  at  35◦C for  18-24  hours. 
Interpretation : Positive  reaction  was  shown  by  the red color. 
Each  batch  of  media  was  tested  with  a  positive  and  negative  
control  organisms. Positive  control- Proteus  species, Negative  control-
Escherichia coli. 
Kligler  iron agar  test:  Principle :This  test  is  based  on  the  the  
ability  of  an  organism  to  attack   specific  carbohydrates  present  in  a  
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basal  medium,  with  or  without  the  production  of  gas  or  hydrogen  
sulphide. 
Procedure :  Organisms  were  picked  up  from  the  top  of  a  single  
colony  from  primary  isolation   plate  with  a  straight  wire  and  
inoculated  by  stabbing  the  butt,  and  then  streaking  the  surface  of  
the  slant. The  results  were  read  only  after  18-24  hours  incubation  at  
35◦C.  
Interpretation :A/A-Acid/ acid ,yellow  color  through out,  Complete  
acidification  of  both  the  slant  and  the  deep.   It  is  produced  by  
lactose  fermenting  organisms. 
K/A –Alkaline/acid –Red/yellow  color. Initial  acidification  of  
both  the  deep  and  slant  of  the  medium  by  bacteria  that  ferment  
glucose, later  the  slant  reverts  back  to  alkaline  pH  as  alkaline  
amines  are  formed  from  peptides  near  the  surface. 
K/K –Alkaline/alkaline- Red  color  in  slant  and  butt. It shows  
peptones  are  utilized, both glucose  and  lactose  are not  fermented. The  
non fermenters  are  unable  to  produce  acids  from  fermentation  of  
glucose  or  lactose  and  there  is  no  change  in  the  medium. 
Production  of  gas  bubbles,  indicate  aerogenic  organism  and  
black  color  in  the  butt  indicates, hydrogen  sulphide  production.  
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Bile esculin agar  
It  was  prepared  by  dissolving  64.5 grams  of  dehydrated  
powder  in  1000ml  of  distilled  water, sterilized  by  autoclaving  at  
121◦C for  15  minutes. The  test  organism  was  inoculated  on  to  the 
surface  of  the  slope  and  incubated  at  37◦ C for  48  hours.  
Blackening  of  the  media  indicated  growth  in  the  presence  of  40% 
bile  and  esculin  hydrolysis. 
Positive  control – Enterococcus  faecalis 
Negative  control- Streptococcus  viridians. 
 
Antibiotic  susceptibility  testing  
This  test  was  done  using  modified   Kirby-Bauer  disc  diffusion  
technique  using  Mueller  Hinton  agar69.   A  single  colony  from  the  
plate  was  taken  with  a  wire  loop,  and  was  inoculated  into  the  
peptone  water. It  was  allowed  to  obtain  turbidity  that  match  with  a  
McFarland  standard. 
Mueller-Hinton  agar  was  prepared  inhouse  according  to  the  
manufacturer’s  instructions. Poured  into  90mm  diameter petri  dishes 
to  a  depth  of  4mm.   Each  batch   was  tested  with  a  control  strain  
of  Enterococcus  faecalis  and  cotrimoxazole  disc. The  zone  of  
inhibition  should  be  20  mm  or  more  in  diameter. 
73 
 
Preparation  of 0.5  Mcfarland  standard 
1. Prepare 1%  w/v  solution  of  sulphuric  acid  by  adding  1 ml  of  
concentrated  sulphuric  acid  to  99  ml  of  water. Mix  well. 
2. Prepare  1% w/v solution  of  barium  chloride  by  dissolving 0 .5 
g of dehydrate  barium  chloride  in  50  ml  of  distilled  water. 
3. Add 0 .6  ml  of  barium  chloride  solution  to  99.4  ml  of  
sulphuric  acid  solution  and  mix. 
This  can  be  stored  at  room  temperature  for  upto  six  months. 
The  0.5  McFarland  standard  provides  an  optical  density  equivalent  
to  the  density  of  1.5 × 108 colony  forming  units/ml. Matching  was  
done  by  holding  the  bacterial  suspension  and  McFarland  tubes  side  
by  side  and viewing  them  against  a black-lined  background. 
Selection  of  antimicrobial  agents  for  testing : 
For  Enterobacteriaceae ,Pseudomonas and  Acinetobacter:  
Ampicillin,  Ciprofloxacin,  Cefotaxime, Amoxy clav,  Norfloxacin,  
Cotrimoxazole,  Nitrofurantoin, Amikacin ,Gentamycin,Meropenem and  
Cefoperazone  sulbactum  discs  were  used. 
For  Gram positive  organisms : 
For Enterococcus : Ciprofloxacin, Amikacin, Vancomycin,  
Nitrofurantoin, cotrimoxazole , Ampicillin,  Norfloxacin  and  Amoxy 
clav discs  were  used.  
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For  streptococcus : Mueller- Hinton  agar  supplemented  with  10%  
sheep  blood  agar  was  used.  
 The   plates  were  dried   before  streaking.  A  lawn  culture  was  
made  with  the  organism  to  be  tested. After  allowing  3-5  minutes  
for  the  agar  to  dry, using  sterile  forceps  antibiotic  discs  were  
placed. The  discs  should  be  about  15  mm  from  the  edge  of  the  
plate  and  not  closer  than  25 mm  from  disc  to  disc.  Within  thirty  
minutes  the  plates  were   incubated  at  37◦C . The  plates  were  read  
on  the  nextday.  The  zone  of  inhibition  around  each  antibiotic  disc  
was  measured . The  sizes  of  zone  of  inhibition  were  interpreted  by  
using   Clinical  and  laboratory  standard  institute  guidelines  as  shown  
below.70 
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Antimicrobial agent Disc 
content 
(mcg) 
Resistan
t 
mm or 
less 
Intermediat
e 
Sensitiv
e  
mm or 
more 
Amikacin  (AK) 
 
30 14 15-16 17 
Gentamicin (G) 
 
10 12 13-14 15 
Nitrofurantoin (NIT) 
 
300 14 15-16 17 
Norfloxacin (Nx) 
 
10 12 13-16 17 
Ciprofloxacin (CIP) 
 
5 15 16-20 21 
Ampicillin(AMP) 
 
10 13 14-16 17 
Cefotaxime(CTX) 
 
30 14 15-22 23 
Amoxycillin/Clavulani
c acid (AMC) 
 
20/10 13 14-17 18 
Cotrimoxazole 
 (COT) 
1.25/23.7
5 
10 11-15 16 
Meropenam (MRP) 10 13 14-15 16 
Vancomycin (VA) 30 14 15-16 17 
Cefoperazone  
Sulbactum (CFS) 
75/10   27-33 
Novobiocin(NV) 30 17 18-21 22 
 
Screening  for  extended  spectrum  betalactamase :  According  to  
CLSI   guidelines, those  organisms  showing  zone  inhibitory  size  less  
than  27mm  for  cefotaxime   was  considered  as  potential  ESBL  
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producers  and  were  subjected  to  confirmatory  tests. Only the  
organisms  such  as  Escherichia coli, Klebsiella  and  Proteus  were  
subjected  to  confirmatory  test. 
Double  disc  synergy  test : 
Test  organism  was  inoculated  in  peptone  water  and  lawn  
culture  was  made  on  Mueller-Hinton  agar as  recommended  for  a  
standard  disk  diffusion  susceptibility  test. Discs  containing  30µg of  
ceftazidime  and  30µg cefotaxime  were  placed  15 mm  apart ( centre to  
centre)  to  the  disc  containing Amoxicillin/Clavulanic  acid (20/10µg). 
Plates  were  incubated  at  37◦ C overnight.  Enhancement  of  zone  of  
inhibition  between  the  clavulanate  discs  and  any  one  of  the  β 
lactam  antibiotic  disc  was     interrupted  as  an  indication  for  ESBL  
production.       
E test :  EM079A  
It  is  a  phenotypic  ESBL  detection  strip  which  is  coated  with  
mixture  of  three  different  cephalosporins  with  and  without  
clavulanic  acid  on  a  single  strip  in  a  concentration  gradient  manner. 
The  upper  half  has  Ceftazidime,  Cefotaxime and  Cefepime + 
Clavulanic  acid  and  Tazobactum  with  concentration gradient  tapering  
downwards. The  lower  half  is  coated  with  Ceftazidime, Cefotaxime  
and  Cefepime  in  a  concentration  gradient  in  reverse  direction.   
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Procedure: 
1. An  inoculam  was  prepared  from  the  pure  culture  of   the  test  
organism . It  was  standardized  with  that  of  the  0.5  McFarland  
standard. 
2. Mueller-Hinton  agar  was  prepared  inhouse  according  to  
manufacturer’s  instructions. 
3. A  sterile  cotton  swab  was  dipped  into  the  standardized  
inoculam  and  was  rolled  to  express  excess  fluid. 
4. Entire  agar  surface  was  streaked  with  the  swab  three  times  
turning  the  plate  at  60◦ angle  between  each  streaking. 
5. Strip  was  removed  from  the  container   with  an  applicator    
and  was  placed  on  the  agar  plate. 
6.  Plates  were  kept  in  the  incubator   and  read  on  the  next  day.  
7. Values  were  read  where  the  ellipse  intersects  the  scale  on  the  
strip. 
Interpretation : The  following  criteria  were  used  for  interpretation 
It  was  interrupted  as  ESBL   positive  When  the  ratio  of  the  value  
obtained  for  (Mix/ Mix+)  was  greater  than  or  equal  to  8,  or  no  
zone  was  obtained  for MIX  and  zone  obtained  in  Mix +. 
It  was  interrupted  as  ESBL  negative  strain  when  the  ratio  of  the  
value  obtained  for  (Mix/ Mix+)  was  less  than  eight. 
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It  was  considered,  non conclusive  for  ESBL  when  no  zone  of  
inhibition  was  obtained  on  either  side. In  such  cases  resistance  may  
be  due  to  some  other  mechanisms  other  than  ESBL  production.  
Quality  control  of  the  strips  were  carried  out  by  testing  the  strips  
with  the  standard  ATCC  cultures. 
Positive  control – Klebsiella pneumonia  ATCC 700603 
Negative  control – Escherichia  coli ATCC  25922. 
 The information collected regarding all the selected cases were recorded 
in a Master Chart. Data analysis was done with the help of computer 
using Epidemiological Information Package (EPI 2002).  
 
 
  
  
Fig. 2  MacConkey agar plate showing lactose fermenting colonies 
Fig. 1  Urine Screening Test 
  
  
Fig. 3 Chromagar plate showing Escherichia Coli 
Fig. 4 Chromagar plate showing Klebsiella pneumoniae 
  
Fig. 5  Enterococcus faecalis on chromagar plate 
Fig. 6 Staphylococcus aureus on chromagar plate 
  
Fig. 7  Acinetobacter and Pseudomonas on chromagar plate 
Fig. 8  Proteus and candida on chromagar plate 
  
Fig. 9  Enterococci on chromagar plate 
Fig. 11  Chromagar plate showing mixed culture 
Fig.10  E.coli on chromagar plate 
  Fig. 12  AST pattern of ESBL Isolate 
  
Fig. 13 Estrip with ESBL positive isolate 
Fig. 14  Estrip with ESBL negative isolate 
  Fig. 15  DDST with ESBL positive isolate 
 Fig. 16  Estrip and DDST with ESBL positive isolate 
  
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
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RESULTS 
 
The  422  urine  samples  collected  from  clinically  suspected  
UTI cases   from  various  departments  such  as  Medicine,  surgery,  
urology, Paediatrics,  Intensive  care  units , and  outpatients  were  
processed  in  Blood agar,  MacConkey agar  and  Chromogenic agar.  
Out  of  this  206 were collected  from males  and 216 were  from  
females .  
 
 
1.  Urine  culture result  among  study  population (n=422) 
 
Culture result No Percentage 
Positive 141 33.4 
Negative 281 66.6 
Total 422 100 
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    2.Type  of  growth  among  positive  isolates( n=141) 
Growth No Percentage 
Unimicrobial 131 92.9 
Polymicrobial 10 7.1 
Total 141 100 
 
 
 
3. Distribution of  Gram positive ,  Gram  negative & other  isolates 
Organisms No Percentage 
Gram negative   108 76.6 
Gran  positive  20 14.2 
Fungus 13 9.2 
Total 141 100 
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4. Distribution  of  organisms  isolated  from  cases  of  urinary tract  
infection (n=141) 
Name of the organism No Percentage 
Escherichia coli 77 54.6 
Klebsiella pneumoniae 15 10.6 
Enterococcus species 14 9.9 
Candida species 13 9.2 
Proteus mirabilis 7 5 
Staphylococcus 
saprophyticus 
4 2.8 
Acinetobacter baumanii 3 2.1 
Proteus vulgaris 2 1.4 
Pseudomonas 
aeruginosa 
2 1.4 
Enterobacter aerogenes 1 0.7 
Streptococcus species 1 0.7 
Citrobacter freundi 1 0.7 
Staphylococcus aureus 1 0.7 
Total 141 100 
 
  
82 
 
5.Organisms  isolated  from  mixed  growth  in  various  media (n=10) 
  
 
6. Sexwise Distribution of the organisms n=141 
Sex No Percentage 
Male 66 46.8 
Female 75 53.2 
Total 141 100 
 
  
Organism Number BAP MAC Chromagar 
E.coli 
+Enterococci  
O+6 4 0 6 
Klebsiella 
+E.coli   
0+1 1 1 1 
E.coli 
+Enterobacter 
0+1 0 1 1 
E.coli+Candida 0+2 2 0 2 
Total 10(100%) 7(70%) 2 (20%) 10 (100%) 
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7. Age  and  sex distribution of the positive isolates (n=141 ) 
Age M F Total (M+F) 
No % N
o 
% No % 
˂  10 26 39.4 13 17.3 39  27.7 
11-20 2 3.1 6 8 8 5.7 
21-30 1 1.5 14 18.7 15 10.6 
31-40 3 4.5 11 14.7 14 9.9 
41-50 6 9.1 17 22.7 23 16.3 
51-60 8 12.1 4 5.3 12 8.5 
Above 60 20 30.3 10 13.3 30 21.3 
Total 66 100 75 100 141 100 
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8. Total number  of isolates  from  Various  Departments (n=141) 
 
 Department No of  organisms 
isolated 
Percentage 
Medicine 40 28.4 
Urology  23 16.3 
Intensive  care 
units(ICU) 
19 13.5 
Obstetrics & 
Gynaecology 
17 12.1 
Paediatrics 16 11.4 
Surgery  14 9.9 
Outpatient (O.P) 12 8.5 
Total 141 100 
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9.Organisms  isolated  from  various culture plates(n=141) 
 
Name of the 
organism 
Number of  
organism 
BAP MAC Chrome 
agar 
No % No % No % 
Escherichia 
coli 
77 77 100 76 98.7 77 100 
Klebsiella 
pneumoniae 
15 15 100 15 100 15 100 
Enterococcus 
species 
14 12 85.7 5 35.7 14 100 
Proteus 
mirabilis 
7 7 100 7 100 7 100 
Proteus 
vulgaris 
2 2 100 2 100 2 100 
Pseudomonas 
aeruginosa 
2 2 100 2 100 2 100 
Staphylococcus 
saprophyticus 
4 4 100 0 0 4 100 
Enterobacter 
aerogenes 
1 0 0 1 100 1 100 
Citrobacter 
freundi 
1 0 0 1 100 1 100 
Streptococcus 
species 
1 1 100 0 0 1 100 
Acinetobacter 
baumani 
3 3 100 3 100 3 100 
Candida 
species 
13 13 100 9 69.2 13 100 
Staphylococcus 
aureus 
1 1 100 0 0 1 100 
Total 141 137 97.2 121 85.8 141 100 
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10. Comparison of isolation of organisms in various media n=141 
 
 
 
 
11. Comparison  of  Chromagar  with  blood  agar 
Chrom agar Blood  agar Total 
P N 
P 137 4 141 
N 0 0 0 
Total 137 4 141 
 
Sensitivity = 100 
Accuracy = 97 
PPV  = 97 
 
  
Name of the 
media 
 Number 
of  isolates 
 
Percentage 
 
Blood agar 137 
97.2 
MacConkey agar 121 
85.8 
Chrome agar 141 
100 
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12. Comparison  of  Chromagar  with  MacConkey  agar 
Chrom agar Mac Conkey agar Total 
P N 
P 121 20 141 
N O O 0 
Total 121 20 141 
 
Sensitivity = 100 
Accuracy = 86 
PPV  = 86 
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 13. Overall sensitivity  and  resistance  pattern of uropathogens to 
antibiotics (n=128 ) 
Antibiotics Sensitivity Resistance 
No % No % 
Ampicillin(A) 21 16.4 107 83.6 
Gentanycin(G) 89 69.5 39 30.5 
Ciprofloxacin(CIP) 63 49.2 65 50.8 
Amikacin(AK) 119 93.0 9 7.0 
Cotrimoxazole(COT) 32 25 96 75 
Nitrofurantoin(NIT) 111 86.7 17 13.3 
Norfloxacin(NX) 44 34.4 84 65.6 
Cefotaxime(CTX) 35 27.34 93 72.7 
Cefoperazone 
sulbactum(CFS) 
105 82.0 23 18 
Amoxyclav(AMC) 60 46.9 68 53.1 
Meropenem (MRP) 128 100 0 0 
 
 
14. Percentage  of  ESBL organisms( n=67) 
Name of the 
organism 
Total number ESBL positivity Percentage 
E.coli 77 52 67.5 
Klebsiella 
pneumoniae 
15 10 66.7 
Proteus species 9 5 55.6 
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15. Comparison  of  ESBL  detection using  the  DDST and Etest 
 
 
16. Comparison  of    E  test  with  DDST  test 
E test DDST  test Total 
P N 
P 63 4 67 
N 0 3 3 
 63 7 70 
Degrees of freedom 132 
Fisher’s exact chi 
square 
18.7286 
‘p’ 0.0006 
 
Sensitivity = 100 
Accuracy = 94 
PPV  = 94 
 
Organisms  positive  
in ESBL  screening 
Organisms positive  in 
double  disc 
approximation test 
Organisms positive 
in E test 
E.coli (54) 48 52 
Klebsiella (10) 10 10 
Proteus (6) 5 5 
Total (70) 63 
(90%) 
67 
(95.7%) 
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17. Sexwise  distribution  of  ESBL positive  isolates (n=67) 
Sex No Percentage 
Male 36 53.7 
Female 31 46.3 
Total 67 100 
 
18. Age  and  sex distribution of ESBL positive isolates (n=67) 
Age group No of positives Total 
 M 
 
F M+F 
˂ 10 14 (  
38.9%) 
 
8(25.8%) 22 (32.8%)  
11-20 2(5.6%) 2(6.5%) 4(6.0%) 
21-30 1(2.8%) 5(16.1%) 6(9%) 
31-40 1(2.8%) 2(6.5%) 3(4.5%) 
41-50 3(8.3%) 7(32.3%) 10(14.9%) 
51-60 6(16.7%) 3(9.7%) 9(13.4%) 
Above 60 9(25%) 4(12.9%) 13(19.4%) 
Total      
36(100%) 
31(100%) 67 (100%) 
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19. Isolation of ESBL producing bacteria from different wards 
(n=67) 
Name of the 
Department 
No of ESBL 
producing bacteria 
Percentage 
Medicine 15 22.4 
Urology  11 16.4 
Outpatient  (O.P) 10 14.9 
Intensive  Care 
unoits(ICU) 
9 13.4 
Paediatrics 9 13.4 
Surgery  8 11.9 
Obstetrics & 
Gynaecology 
5 7.5 
Total 67 100 
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20.A
ntibiotic  sensitivity and resistance pattern of G
ram
 negative isolates 
A
ntibiotics 
E.coli 
(n= 77) 
K
lebsiella 
(n= 15) 
Proteus 
(n=9) 
A
cinetobacter 
(n=3) 
Pseudom
onas  
(n=2) 
S 
R
 
S 
R
 
S 
R
 
S 
R
 
S 
R
 
A
m
picillin 
15 
(19.5%
) 
62 
(80.5%
) 
1 
(6.7%
) 
14 
(93.3%
) 
1 
(11.1%
) 
8 
(88.9%
) 
- 
- 
- 
- 
G
entam
ycin 
62 
(80.5%
) 
15 
(19.5%
) 
12 
(80%
) 
3 
(20%
) 
7 
(77.8%
) 
2 
(22.2%
) 
2 
(66.7%
) 
1 
(33.3%
) 
2 
(100%
) 
- 
C
iprofloxacin 
30 
(39%
) 
47 
(61%
) 
11 
(73.3%
) 
4 
(26.7%
) 
8 
(88.9%
) 
1 
(11.1%
) 
2 
(66.7%
) 
1 
(33.3%
) 
2 
(100%
) 
- 
A
m
ikacin 
73 
(94.8%
) 
4 
(5.2%
) 
13 
(86.7%
) 
2 
(13.3%
) 
9 
(100%
) 
0 
3 
(100%
) 
0 
2 
(100%
) 
- 
C
otrim
oxazole 
18 
(23.4%
) 
59 
(76.6%
) 
4 
(26.7%
) 
11 
(73.3%
) 
2 
(22.2%
) 
7 
(77.8%
) 
0 
3 
(100%
) 
0 
2 
(100%
) 
N
itrofurantoin 
76 
(98.7%
) 
1 
(1.3%
) 
11 
(73.3%
) 
4 
(26.7%
) 
- 
- 
1 
(33.3%
) 
2 
(66.7%
) 
1 
(50%
) 
1 
(50%
) 
N
orfloxacin 
17 
(22.1%
) 
60 
(77.9%
) 
6 
(40%
) 
9 
(60%
) 
4 
(44.4%
) 
5 
(55.6%
) 
0 
3 
(100%
) 
0 
2 
(100%
) 
C
efatoxim
e 
23(29.9%
) 
54(70.1%
) 
5(33.3
%
) 
10(66.7%
) 
3 
(33.3%
) 
6 
(66.7%
) 
2(66.7%
) 
1(33.7
%
) 
1(50%
) 
1 
(50%
) 
C
efoperazone 
sulbactum
 
74 
(96.1%
) 
3 
(3.9%
) 
15 
(100%
) 
- 
9 
(100%
) 
0 
3 
(100%
) 
0 
2 
(100%
) 
- 
A
m
oxycillin 
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21.Antibiotic  sensitivity and resistance pattern of Gram positive 
isolates 
 
 
 
 
 
 
Antibiotics Enterococci 
(n=14) 
Staph saprophyticus 
(n=4) 
Staph aureus 
(n=-1) 
S R S R S R 
Ampicillin 1 
(7.1%) 
13 
(92.9%) 
1 
(25%) 
0 1 
(100%) 
0 
Gentamycin - - 3 
(75%) 
1 
(25%) 
0 1 
(100%) 
Ciprofloxacin 3 
(21.4%) 
11 
(78.6%) 
3 
(75%) 
1 
(25%) 
1 
(100%) 
0 
Amikacin 12 
(85.7%) 
2 
(14.3%) 
4 
(100%) 
0 1 
(100%) 
0 
Cotrimoxazole 0 14(100%) 2(50%) 2(50%) 1(100%) 0 
Nitrofurantoin 14 
(100%) 
0 4 
(100%) 
0 1 
(100%) 
0 
Norfloxacin 0 14 
(100%) 
1 
(25%) 
3 
(75%) 
0 1 
(100%) 
Cefatoxime 13 
(92.9%) 
1 
(7.1%) 
2 
(50%) 
2 
(50%) 
1 
(100%) 
0 
Cefoperazone 
sulbactum 
14 
(100%) 
0 4 
(100%) 
0 1 
(100%) 
0 
Amoxycillin 
Clavulanic acid 
3 
(21.4%) 
11 
(78.6%) 
4 
(100%) 
0 1 
(100%) 
0 
Vancomycin 14 
(100%) 
0 - - - - 
94 
 
22. Comparison  of  resistance  pattern  of  ESBL  and  non ESBL 
E.coli 
Antibiotics Total no of 
resistant 
organisms 
ESBL 
E. coli(n=52) 
Non –ESBL   E. 
coli(n=25) 
Ampicillin 62 50 
(96.2%) 
12 
(48%) 
Gentamycin 15 12 
(23.1%) 
3 
(12%) 
Ciprofloxacin 47 34 
(65.9%) 
13 
(52%) 
Amikacin 4 4 
(7.7%) 
0 
Cotrimoxazole 59 44 
(84.6%) 
15 
(60%) 
Nitrofurantoin 1 1 
(1.9%) 
0 
Norfloxacin 60 43 
(82.7%) 
17 
(68%) 
Cefotaxime 54 52 
(100%) 
2 
(8%) 
Cefoperazone 
Sulbactum 
3 3 
(5.8%) 
0 
Amoxicillin 
clavulanic acid 
39 31 
(59.6%) 
8 
(32%) 
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23.Comparison  of  resistance  pattern of   ESBL  and  non  ESBL  
Klebsiella 
Antibiotics Total 
number of 
resistant 
organisms 
ESBL 
Klebsiella 
(n=10) 
Non ESBL 
Klebsiella 
 (n=5) 
Ampicillin 14 10 
(100%) 
4 
(80%) 
Gentamycin 3 2 
(20%) 
1 
(20%) 
Ciprofloxacin 4 4 
(40%) 
0 
Amikacin 2 2 
(20%) 
0 
Cotrimoxazole 11 9 
(90%) 
2 
(40%) 
Nitrofurantoin 4 3 
(30%) 
1 
(20%) 
Norfloxacin 9 6 
(60%) 
3 
(60%) 
Cefotaxime 10 10 
(100%) 
0 
Cefoperazone 
Sulbactum 
- - - 
Amoxicillin 
clavulanic acid 
8 7 
(70%) 
1 
(20%) 
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 Table 1 indicates that  among  the  422 (100%) samples,  281 
(66.6%)  samples  yielded  no  growth   in  any of  the  media  and  
growth  was  obtained  from  141(33.4%) samples. 
Among  the  141  samples  which  were culture  Positive,  131  of  
them  showed  a  single  isolate  (92.9%).  Ten    (7.1%)  of  the   samples  
showed  more  than one  type  of  organism  and  was  considered  as  
mixed  growth. (Table 2).  
Table 3  shows  the  distribution  of  Gram positive  and  Gram  
negative  bacteria  and  other  isolates. Out  of  141  positive  isolates , 
Gram  negative  organisms  predominate  showing  108 (76.60%) . The  
Gram  positive  organisms  and  Candida species  were  isolated at  a  rate  
of  20 (14.18%) and 13 (9.22%)  respectively. 
The  isolation  rate  of  uropathogens  were shown  in  Table 4. 
Among  the  isolates  Escherichia coli  was  the  predominant organism. 
77(54.60%) . Other  organisms  isolated  in  decreasing  order  were  
Klebsiella pneumoniae 15(10.63%), Enterococcus  faecalis14(9.92%),  
Candida albicans13(9.21),  Staphylococcus saprophyticus 4( 2.83%)  
Proteus mirabilis 7(5%),Proteus vulgaris2(1.4%), Acinetobacter baumanii 
3(2.12%), Pseudomonas aeruginosa 2(1.41%), Enterobacter aerogenes 
97 
 
1(0.70%), Staphlococcus aureus 1(0.70%), and Streptococcus  
species1(0.70%) . 
Table 5  shows  the  isolation  of  predominant  organism  from  
mixed  culture  in  various  media. All  the  predominant  isolates  from  
mixed  culture(100%)  were  isolated  in  chromagar  whereas  20% and  
70%  of  isolates  were  identified  from  MacConkey  agar  and  blood  
agar.   
Table 6 depicts  the  sexwise  distribution  of  the  isolates.  Among   
the  141  positive  isolates,  growth  from  samples  collected  from  males  
were  66 (46.8%) and  from  females were  75 (53.2%) .Females  
predominate  with  female  to  male  ratio  of  1.2:1.  
Age  and  sex wise  distribution  of  the  positive  isolates were  
shown  in  the  Table 7. In males the common  age  group  affected  were  
below  10 years  and above 60 years.   In females,  21-50 years  were the  
age  group commonly affected. 
The   rate  of  isolation  of  organisms  from  different  wards  were  
shown  in  Table 8. Among  these  Medicine  wards40 (28.4%) showed  
highest  percentage  of  positive  isolates. The  isolation  rate  among  
other  wards  were  urology ward 23(16.3%), Intensive care units 19 
(13.5%),   Obstetrics and  Gynaecology  ward 17(12.1%), Paediatrics 
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ward 16(11.4%), Surgery ward 14(9.9%) and out patients 12(8.5%).The  
positive  culture  was  less  from  outpatient department. 
The  rate  of  isolation  of  organisms  in  blood agar, MacConkey 
agar and  chromogenic agar  were  depicted  in  Table  9 . All the  141  
isolates  were  identified  in  chromogenic  agar  whereas  from  Blood 
agar  and  MacConkey  agar  137  and  121  organisms  were  identified  
respectively. All  the  pathogens  were  isolated  in chromagar 
141(100%). In blood agar all  the  organisms  were  isolated  (100%) 
except  Enterococcus, Citrobacter  and  Enterobacter. In MacConkey 
agar all  other  organisms  showed  100%  isolation  rate  except  E.coli  
(98.7%), Enterococci (35.7%) and  Candida (69.2%). Most  of  the  
organisms  identified  in  chromogenic agar  which  were  not  identified  
from  blood  agar  were  from  mixed  cultures. 
The  isolation  rate  in  various  media  were  compared  in  Table 
10  which  showed  statistically  significant  difference. The isolation  of  
organisms  from   Chromogenic agar was 100%. whereas it was  97.2% 
from blood agar and 85.8% from  MacConkey agar. Chromogenic agar  
showed  maximum  number  of  organisms.Escherichia  coli  from  
chromagar  were  confirmed  by  spot  indole  test. 
Table 11  shows,  the  comparison  of  chromogenic  agar  with  
blood  agar.  Out  of  141  isolates,  137  isolates  were  identified  from  
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blood  agar  and  4  isolates  were  not  identified  from  blood  agar.  All  
141  isolates  were  identified  from  chromogenic  agar. The  sensitivity  
is  100%  ,PPV  is  97%, accuracy  is  97%. 
The  comparison  of  chromogenic  agar  with  MacConkey  agar. 
Out  of  141  isolates  121  were  identified  from  MacConkey  agar  and  
20  were  not  identified  from  MacConkey  agar. (Table 12). The  
sensitivity  is  100%,  PPV  is  86%,  accuracy  is  86%. 
The  overall  sensitivity   and  resistance  pattern  of  uropathogens  
were  shown  in  Table 13 .All  the  organisms  were 128(100%)  
sensitive  to  Meropenem. The  highest  sensitivity  was  shown  to  
Amikacin  119(92.97%),  and  the  lowest  sensitivity  was  shown  to  
Ampicillin 21(16.41%). The  sensitivity  to  all  other  antibiotics  were , 
for Nitrofurantoin 111 (86.72%), Cefoperazone sulbactum 105 (82.03%),  
Gentamycin 89 (69.53%), Ciprofloxacin 63(49.22%), Norfloxacin 
44(34.38%),, Cefotaxime 35 (27.34%), Cotrimoxazole 32 (25%) and 
Ampicillin 21 (16.41%). 
All  the  Cefotaxime  resistant  isolates of  E. coli , Klebsiella and 
Proteus  were  subjected  to  confirmatory  tests  by  double  disc  
approximation  test  and  E  tests.  The  results  were  shown  in Table 14 
. Among  the  67  ESBL  positive  isolates  , Escherichia coli  52 (67.5%) 
was  the  predominant  ESBL producing  organism . The  ESBL positive  
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isolates  among  Klebsiella  and  Proteus  were 10 (66.7%) and  5(55.6%) 
respectively. 
The  comparison  of  ESBL  detection  using  double  disc  synergy  
test  and  E test  was  depicted  in Table 15. Out  of  70 isolates  which  
were  positive  in  screening  tests,  63  were detected as  ESBL  
producers  from  double disc  synergy  test  and  67  were detected  in  E 
test.  Out  of  these  two  tests  E test  detected  maximum  number  of  
organisms  (95.7%) compared  to  DDST  (90%) 
Out  of  70  screening  positive  isolates ,  67  were  positive  in  
Etest,  whereas  63  were  positive  in  DDST  test. 7 organisms  were  
negative  in  DDST  test  and  only  3  organisms were  negative  in  E 
test. There  was  statistically  significant  association  between  E test  and  
DDST  test.  P value 0.0006 (Table 16). 
The   sex  wise  distribution  of  ESBL positive  isolates  were  
shown  in  Table 17.  The  isolation  rate  was  more  in males 36(53.7%)  
compared  to  females  31(46.3%). 
ESBL  isolates  were  more  common  in  0-10 years  age  
group(32.8%) in both  sexes. Another  peak  was  shown  in  above  60  
years  age  group.(19.4%).Table 18.  
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The  isolation  of  ESBL organisms  from  various  wards  were  
shown  in  Table 19 . ESBL strains  were  isolated  predominantly  from 
Medical  ward (22.4%)  followed  by  urology  ward (16.4%). 
The  antibiotic   sensitivity  pattern  of  predominantly  isolated  
Gram  negative  organisms  were  shown  in  Table 20. It  revealed  that 
apart  from  Meropenem (100%) the  maximum  sensitivity  for  
Escherichia.coli  was  seen  with  Nitrofurantoin (98.7%),  followed  by  
Cefoperazone sulbactum(96.1%)  Amikacin (94.8%),   Gentamycin 
(80.5%)  and  amoxy clavulanate(49.4%). The  maximum  resistance was 
seen  against  Ampicillin (80.5%), Norfloxacin (77.9%), Cotrimoxazole 
(76.6%), Cefotoxime  (70.1%) and  Ciproflxacin(61%) . 
Klebsiella pneumoniae was  most  sensitive  to Meropenem 
(100%0  Cefoperazone sulbactum( 100%)  followed  by  Amikacin 
(86.7%), Gentamycin 12(80%),Ciprofloxacin 11(73.3%), Nitrofurantoin 
11(73.3%) Maximum  resistance  was  seen  with  Ampicillin (93.3%), 
Cotrimoxazole 11(73%), Cefotaxime 10(66.7%),Norfloxacin9(60%)  and  
amoxyclav 8(53.3%).  
Proteus species were  most  sensitive  to Meropenem (100%) 
Amikacin  and  Cefoperazone sulbactum (100%).The  highest  percentage 
of  resistance  was shown  for  Ampicillin(88.9%). 
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Acinetobacter  baumanii  showed  100%  sensitive  to  Meropenem, 
Amikacin and  Cefoperazone sulbactum  and  100%  resistant  to  
Cotrimoxazole  and  norfloxacin. 
Pseudomonas  aeruginosa  were  100%  sensitive  to  Meropenem, 
Cefoperazone  sulbactum, and Amikacin  and  100%  resistant  to  
norfloxacin and  Cotrimoxazole. 
The   antibiotic   sensitivity  pattern  of  Gram positive  organisms  
which  were  isolated commonly  were  depicted  in  Table 21. The  
Enterococcus  were  most  sensitive  to  Vancomycin 14 (100%), 
Cefoperazone sulbactum (100%) and Nitrofurantoin(100%) and were  
resistant  to Ampicillin 1 (7.1%). Staphylococcus  saprophyticus   was  
most  sensitive  to  Amikacin 4(100%), Amoxy clav 4 (100%), 
Cefopreazone  sulbactum 4(100%) and Nitrofurantoin 4 (100%). 
Stapylococcus  aureus was sensitive  to  Ampicillin, Ciprofloxacin, 
Amikacin,  Nitrofurantoin, Cotrimoxazole , Cefoperazone  sulbactum  
and Amoxy clav (100%) and  resistant  to  Gentamycin  and 
Norfloxacin(100%). 
The  resistance  pattern  of  ESBL and non ESBL E. coli were 
compared in Table 22. The  ESBL Escherichia coli  isolates  showed 
highest  resistance  towards  Cefotaxime 52(100%),  Ampicillin 
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50(96.2%),  Cotrimoxazole 44(84.6%),  Norfloxacin 43(82.7%)  and 
Ciprofloxacin 34(65.9%) compared to non ESBL stains. 
The   resistance  pattern  of  ESBL and non ESBL Klebsiella  were 
compared  in Table 23 .  The ESBL  Klebsiella  strains  were  highly 
resistant  towards Cefotaxime 10 (100%), Ampicillin 10(100%), 
Cotrimoxazole 9(90%), Amoxy clavulanic acid 7(70%) and Norfloxacin 
6(60%) 
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DISCUSSION 
The  gold  standard  for  the  diagnosis  of  UTIs, is  the   culture  of 
urine  samples  on  solid  media. Blood agar  and  MacConkey  are  the  
conventional  media  used  in  our  laboratory. The present  study  ,  
evaluated  chromogenic media , for  its effectiveness  as  a medium  for  
direct  isolation  of  organisms  from  urine  samples. Previous  studies  
have  demonstrated  equal  or  superior  performance  of  chromogenic  
media  compared  to  conventional  media  for  the  isolation  and  
identification  of  uropathogens.  The  results  from  this  study  were  in  
agreement  with  prior  reports.                                   
In  case  of most  of  the   urinary  tract  infections , antibiotics  are  
given  empirically   before  the  laboratory  results   are  available. Current  
knowledge  of  the  organisms  that  cause  urinary  tract  infection  and  
their  antibiotic  susceptibility  pattern  is  mandatory, to  ensure  
appropriate  therapy. 
Prevalence  of  the  organisms     
From  the  141 (33.4%)  positive  growth  , 131   (92.9%)  were  
unimicrobial  and  10(7.1%)  were  polymicrobial.  This  was  slightly  
higher  the  study  done  by  Leeela rani et al., 72, which  revealed  95.8%  
were  unimicrobial  and  4.12%  were   polymicrobial  growth.  The  
study  done  by  V.Lakshmi  et  al.,73 , obtained   95.12%  unimicrobial   
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and  4.87% polymicrobial  growth.  Other  study    by  Soley Sharmin.6,  
showed  90.6% unimicrobial  and  9.4% polymicrobial  growth  which  
was  similar  to  our  study. This  study    had  slight  difference  with  the  
study  done  by  R  Praveen et al.,5  which  showed 31.67%  unimicrobial  
and   2%  polymicrobial  growth. 
In   the  present  study   Gram  negative  organisms  were  
responsible  for  76.6%  of  UTI s  and    Gram  positive  organisms were  
responsible  for  14.2%  of  UTI s  and  the  remaining  9.2%  were  
caused  by  candida. The  studies  by  Arwa M Abdullah  et  al., 74 
showed  75.33%  of  UTI  were  caused  by  Gram  negative  and  24.66% 
by Gram  positive  bacteria.  Another  study  by  Z. Samra  et  al., 3 
showed  70%  of   Gram negative  organisms  ,  26%    Gram positive  
organisms  and  4%  of   Candida species were  responsible  for  UTI s.. 
The present  study  showed  slight  decrease  in  isolation  of  Gram  
positive  organisms,  but  greater  recovery of  candida. The  Candida  
species   in  our  study were   commonly  isolated  from  diabetic  and  
patients  aged  above  60  years. 
All  the  organisms  isolated  from  chromogenic  agar  were 
consistent  with  the  manufacturer’s  description. Escherichia coli  77 
(54.6%) was  the  predominant  organism  isolated.  This  is  similar  to  
the  study  done  by  Chaudhary  Navin  kumar  et  al., 75 which  
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showed  52.4%  of  E.coli  and  another  study by Sohely sharmin et al.,6 
which  showed  53.2% of  E.coli.  
The  isolation  rate  of  Klebsiella pneumoniae(10.6%) and  
Enteococcus (9.9%)  in  our  study,  were  also  similar  to  the  study  by  
Sekikawa Elly 2011.,76 which  showed  the  isolation  rate  of Escherichia 
coli ( 55.4%),  Klebsiella pneumoniae (9.5%), and  Enterococcus ( 9.5%).  
Another study  by  Sohely Sharmin et al .,6 the  isolation  rate  of   
Klebsiella  was 10.7%  and  Enterococcus  was 10.7%. In  all  these  
studies  chromogenic  media  were  used  for  the  isolation  of  urinary  
tract  pathogens.   In a study  by  Tambekar  et  al.,  77Pseudomonas  
aeruginosa  was  the  second  common  isolate. In  all other  studies , 
similar  to  our  study  Klebsiella  pneumoniae was  the  second  common  
isolate. 
In  the  present  study  isolation  of  organisms  from  mixed  
cultures  were  100%  in  chromogenic agar. This  was  similar  to  the  
study  done  by  R Parveen  et al.,5  and  Leela  Rani  et  al72  which  
also  showed  similar  results. 
Comparison  of  chromagar  with  Blood agar and MacConkey agar  
The  isolation  of  organisms  from  Blood agar(97.2%),  
MacConkey  agar  (85.8%) and  Chromogenic  agar (100%)  in  our  
study  , showed  similar  isolation  rates  as  that  of   the  study  by    
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Leela Rani  et  al  2012.,72 ( Blood agar (97.5%), MacConkey agar 
(88.1%)).  Enterococcus  produced characteristic tiny  blue  appearance   
which  was  more  easily identified  by  Chromogenic  agar. Due  to  the 
characteristic  color  and  morphology  they  can  be  easily  identified  
from  mixed  cultures. Klebsiella,  Enterobacter  and  Citrobacter  
produced  similar  colony  colors  which  were  further  identified  by  
biochemical  reactions. This  was  also  observed  in  a  similar  study  by  
Lakshmi  et  al.73 In  the  studies  by  Sekikawa Elly76  and               
Lakshmi  et  al .,73 they  observed  a few  strains  of Escherichia coli  and  
Klebsiella  strains  did  not  produce  proper  colors ,  and  were  
identified  by  further  biochemical  reactions. No  such  discrepancy  was  
noted  in  our  study.  
Similar  to  our  study  ,  studies  by  Leela Rani et al ., 72 
V.Lakshmi  et al.,73 and  J D Perry  et al., 78 observed  easy  
identification  of  organisms  from  mixed  cultures  in  Chromogenic  
agar  and  also  in  identifying  contaminated  samples. 
In  a  study  done  by  Jeyshri  Pethani  et al., 79,  the  
antimicrobial  susceptibility  testing  was  done  from  the  Chromogenic 
agar  which  revealed  equivalent  susceptibility  results  as  compared  to  
the  susceptibility  tests  done  from  Blood  agar  or  MacConkey  agar. 
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Swarming  of  Proteus  was  limited  in chromogenic agar ,  in  our  
study  and  all  other  studies    conducted  by  others.  
Since  the  presumptive  identification  of  the  common  organisms  
were  possible  in  the  primary  plate  itself  ,  it  was  observed  that  the  
turn  around  time  of   reporting   the  urine  culture  could  be  reduced.  
This  would  help  in  starting  early  and  appropriate  antibiotic  therapy. 
Cost  is  an  important  issue,  if  a  laboratory  is  introducing  a  
new  method.  Chromogenic  media  though  more  expensive , can  be  
cost  effective  due  to  easier  recognition  of  significant  isolates  from  
culture  plates  and  more  accurate  detection  of  mixed  cultures. The  
study by  Retelj and Harlander.,80  have  concluded  that  chromogenic  
media  for  urinary  tract  pathogens  is  cheaper  than  conventional  
methods   only  when  there  is  high  rate  of  isolation  of   organisms  
such  as  Escherichia coli, Enterococci  Klebsiella  and  Proteus. 
Age  and  sex  distribution  of  UTI   
In  our  study  more  pathogens  were  isolated  from  
females(53.2%)  than  males (46.8%). This  was  in  correlation  with  the  
study conducted  by  Sabrina J Moyo et al., 81 in  which   the  isolation  
of pathogens  from  females  were  at  a rate  of 54.4%  and  from  males  
were  at  a  rate  of  45.6%. Another  study  by  B.Sasirekha 2013.,82 , 
also showed  that  females (51.3%)  were  affected  more  commonly  
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than  males (48.6%). Anatomic  factors  like  short  urethra , hormonal  
factors  and  pregnancy  contribute  to  the  female  preponderance  of  the  
UTI s. 
Our  study  demonstrated  that  the  highest  incidence  of  urinary  
isolates  were  from  21-50 (36.9%)  years  age  group. This  is  in  
coincident  with  the  study  by  S.Shafiyabi et al  2014.,83. In  this  study  
there  is  a  peak  incidence  of  UTI  was  noted  in  the  age  group  
between  21-50 years. (55%). 
This  result  proves  that  among  females   the  sexually  active  
and  child  bearing  age  group  were  more  vulnerable  to  UTIs.   0-10  
years  were  the  age  group commonly  affected  in  both  sexes  in  our  
study.. This  is  similar  to  the  study  by  Dr.Sumer singh., 84, in  which  
children  were   the  second  predominant  group (24%) .  More  number  
of  samples  from  paediatric  wards which  could  be  the  possible  
reason  were  attributed  to  uncircumcision   and  vesicouretral  reflux. 
Acute  diarrohea  ,  respiratory  tract  infections and  malnutrition  are  
also  some  of  the  causes  for  UTIs  in  children.     Another  small  peak  
incidence  in  the age  group  of  above  50  years  (29.8%)  were  noted .  
This  proves  that,  this  age  group  is  more  vulnerable  to  UTIs  
because  of  the  risk  factors  like  poor  emptying  of  the  bladder  due  
to  neurogenic  causes  and  urinary  tract  obstruction . 
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Antibiotic  susceptibility  pattern 
The   overall  antibiotic  sensitivity  pattern    of  the  uropathogens  
in  our  study  showed   higher  sensitivity  to   Meropenem(100%) 
,Amikacin (93%)  and  Nitrofurantoin(86.7%). There  was  a  higher  
degree  of  resistance  towards  Ampicillin(83.6%)  and  Cotrimoxazole ( 
75%). This  was  in  accordance  with  the  study  of  Sandhiya R et al.,85 
where  the  uropathogens  showed  a  higher  degree   of   sensitivity   
towards  nitrofurantoin  and  Amikacin. Chaudhary  U  et al .,86. have  
proved  that  uropathogens  were  100%  sensitive  to  
Meropenem.Another  study  by  Durgesh  D  et  al.,87  showed  that  there  
was  a  high  degree  of  resistance  towards  Ampicillin(79%),  similar  to  
our study. 
Another  study  by  Gaurav Dalela et al., 88 showed  that  there  
was a  high  degree  of   resistance  towards  Cotrimoxazole (78.9%), 
Cefotaxime (78.2%), Amoxy-clavulanate (82.4%) and Norfloxacin 
(67.6%). This  is  similar  to  our  study  where  the  resistance  was  75%, 
72.7% ,53.1% and  65.6% for  Cotrimoxazole, Cefotaxime, Amoxy-
clavulanate and  Norfloxacin  respectively. 
ESBL  detection    
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In our  study  , ESBL  sceening  was  done  using  Cefotaxime disc  
which was similar  to    the   study  done  by  N M Suryawanshi  et al.,89.  
In  this,  they  have  proved  that   all  the  ESBL  producers  were  
uniformly  resistant  to  all  three  third generation  cephalosporins 
(Cefotaxime, Ceftriaxone and  Ceftazidime).  Confirmation  was  done  
by  double  disc  synergy  test  and  Etest.90 .Out  of  70  isolates  which  
were  positive  ESBL  producers  in  screening  test  ,  63(90%)  were  
positive  in  DDST test  and  67  (95.7%)  were  positive  in  Etest. Two  
Escherichia  strains  and  one proteus  strain   produced  inconclusive  
results. This  could  be  due  to  some  other resistance  mechanism  other  
than  ESBL production  such  as AmpC.91production. Our  study  shows  
that  E  test  was  more  sensitive  compared  to  double  disc  synergy  
test  which  was  also  proved  in  a  study  by  Martin  G  Cormican  et  
al.,66.A  study  by  Anandakumar  et  al., 111 showed  that  E test  was  
100%  sensitive  and  97.6%  specific  with  97.3%  positive  predictive  
value. Another  study  by  Dr. Pavani  et  al .,112 also  showed  100%  
sensitivity  for  DDST  and  87.5%  specificity  for  DDST. 
Prevalence  of  ESBL  in  E.coli ,  Klebsiella and  Proteus 
According  to  our  study  67.5% of Escherichia coli, 66.7%  of  
Klebsiella  and  55.6%  of Proteus  were  confirmed  as  ESBL  
producers.  A  a study  by  Anbumani  Narayanasamy  et al.,92  
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indicated  that  the  prevalence  of  ESBL  varies  from  28%  to  84%. In  
our  study   high  rate  of  ESBL  was  seen  in Escherichia coli  isolates  
followed  by  Klebsiella  and  Proteus.  Our  study  correlates  with  the  
Studies  by  S Baby padmini  et  al.,  Rugved  Kulkarni et  al . , 
S.Krishna kumar et  al. , Venkatadri  Babu  et  al., Ramesh Kumar 
M.R  et  al .,  and   Umadevi  S et al 2011., which  showed  that  
Escherichia coli  was  the  commonest  ESBL  producer.93,94,95,96,97,98  
Other  studies by  Venkatadri Babu  et  al  2014.,96  and  Omar B 
Ahmed et al., 99 2013 showed  that   Klebsiella pneumoniae  was  the  
common ESBL  producers. 
The  ESBL  percentage  of  Escherichia coli   in  our  study  
coincides  with  the  study  by  Omar B Ahmed et al.,99 which  showed  
65%  of  Escherichia coli   were  ESBL  producers. The  study  by  
Rugved   Kulkarni  et  al 94., and  S.Krishnakumar  et al., 95 showed  
40.7%  and  44.4% of  ESBL  producing  Escherichia coli  respectively. 
This  is   lower  than  the  isolation  of  ESBL  Escherichia coli  in  our  
study.  Other  study  by  Umadevi  S et al .,98 showed  a   higher  
prevalence  of  ESBL Escherichia coli (81%).  The  same  study  also  
showed  that  the   prevalence  of  ESBL   producing  Klebsiella  were  
74%, which was  higher  than  the  rate  of  ESBL  Klebsiella  in  our 
study.  Other  studies  by  Rugved Kulkarni et al.,94  (15.9%) and  
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S.Krishnakumar  et  al .95, (37.0%)  isolated  lower  percentage  of  
ESBL  producing  Klebsiella. The  study  in  Coimbatore  by  
BabyPadmini et al.,93  during  2004,  showed  41%  of  ESBL  E.coli  
and  40%  of     ESBL  producing  Klebsiella .  This  is  lower  than  the  
ESBL  isolates  in  our  study.  The  rate  of  ESBL  production  in  
Proteus  was  48.9%  and  33.3%  respectively  by  the  studies  conducted  
by  Jitendra Kumar Pandy.,100  and  Omar  B Ahmed .,99  which  was  
slightly  lower  than  our  study.  
Age  and  sex  prevalence  of  ESBL  isolates   
In  our  study  the  ESBL organisms  were  more  commonly  
isolated  from  males (53.7%) than  females (46.3%). This  is  in  
similarity to  the  studies  by  Pankaj Baral  et al .,101 which  showed  
males  were  most  commonly  affected  than  females.  Males are  usually  
less  prone  to  UTI s  as  compared  to  females  because  of  the  longer  
course  of  urethra  and  bacteriostatic  prostatic  secretions.  ESBL 
producing  strains  can  overcome  this  barrier  and  hence  there is  
higher  incidence  in  males. This  fact  was  also  proved  in  the  study  
by  E  Mahesh  et  al.,102 This  is  in  contrast  to  the  study  by         
Datta P et al.,103  which  showed    female  preponderance.   
Majority  of  ESBL  isolates  were  from  Medicine  wards. This  is  
in  similarity  with  the  study  by  Vipul M Khakhkhar  et al.,104 where  
the  isolation  was  more  common  from  Medicine  ward. 
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In  our  study  the  most  common  age  group  affected  were  
children  below  ten  years   and  above  60 years  age  group.  This  is in  
similarity  with  the  studies   by  Mehrgan  et  al., 105 and  Sabrina J 
Moyo et al .,81  This  could  be  explained  by  the  fact  that, immune  
system  is  not  well  developed  in  children  below  one  year  and  also  
congenital abnormalities  like  posterior  urethral  valves  and  
uncircumcision  contribute  to  the  infection  in  children.   In  the  elderly  
due  to  instrumentation  the  local  immunological  barrier  would  have  
been  destroyed  which  favours  the  spread  of  infection  and  also  
diabetes ,  menopause  and  other  immunocompromised  states  
contribute  to infection  by   resistant  organisms. 
Antibiotic  susceptibility  pattern  of  ESBL  and  non ESBL 
organisms 
The  sensitivity  pattern  of  Escherichia coli  revealed  that  
maximum  sensitivity  was  shown  towards  Nitrofurantoin, 
Cefoperazone sulbactum  and  Amikacin.  Other  than  beta lactum  
antibiotics  ESBL  strains  showed  maximum  resistance  towards  
Gentamycin, Ciprofloxacin, Norfloxacin  and  Cotrimoxazole. Compared  
to  non  ESBL  isolates  this  resistance  was  statistically  significant.  
This  showed  that  ESBL  strains  exhibit  co  resistance  for  
fluroquinolones , aminoglycosides and  cotrimoxazole.. The  study  by  
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Swaminathan  ranjan.,106  also  showed  that  ESBL  E.coli  strains  
were  highly  resistant  to  Gentamycin,  Norfloxacin, Cotrimoxazole  and  
Ciprofloxacin. ESBL  E.coli  strains  showed  high  sensitivity  towards  
Nitrofurantoin  and  Amikacin. 
The  resistance  pattern  of  ESBL  Klebsiella  showed  high  
resistance  towards  Cotrimoxazole  and  Norfloxacin  apart  from  
betalactam  antibiotics. A  study  by  Anil  Chander  et al., 107 showed  
similar  results. The  study  by  S.Shafiyabi  et  al .,83 showed  that  there 
was  an  increased  resistance  towards  Amikacin .  This  was  
contradictory    to  our  study  and  many  other  studies  which  showed  
that  there  was  high  sensitivity  towards  Amikacin.  In  a  study  
conducted  by  Mohammed  Rashid  et  al., 108  Escherichia coli  and  
Klebsiella  isolates  were highly  resistant  against  nitrofurantoin   This  
is  in  contrast  to  our  study  where  the  sensitivity  towards  
nitrofurantoin  was  high. 
Carbapenems  are  the  most  effective  and  reliable  beta  lactams  
as  they  are  highly  resistant  to  the  hydrolytic  activity  of  all  ESBL  
enzymes  due  to  trans hydroxyl  ethyl  group.  Since  they  are  the  only  
option  in  case  of  highly  resistant  strains they  should  be  kept  as  a  
reserve  drug  for  treating  complicated  cases. 
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All  though  ESBL  activity  is  inhibited  by  beta  lactamase  
inhibitor,  UTIs are  the  only  infections that  may  be  treated  with  beta  
lactam - beta  lactamase inhibitor  combination. In  this  instance  beta 
lactamase  inhibitor concentration  is  high  enough  to  counteract  the  
hydrolytic  activity  of  ESBLs.They exert  in  vitro  pressure  on  ESBL s  
their  by  facilitating  their  reverse  mutation.86 
Our  study  suggests  Nitrofurantoin  as  the  first  line  drug  
against  UTI  before  culture  and  sensitivity  is  done.  It  is  cost  
effective  and  readily  available.  It  is  also  safer  in  pregnancy.  The  
high  level  susceptibility  of  uropathogens  to  nitrofurantoin  may  be  
influenced  by  its  narrow  spectrum  of  activity,  limited  indication,  
narrow  tissue  distribution  and  limited  contact  with  bacteria  outside  
the  urinary  tract109. It  has  been   proved  that  since  nitrofurantoin  has  
multiple  mechanisms  of  action , thereby  requiring  organisms  to  
develop  more  than  a  single  mutation  in  order  to  develop  
resistance.110.  
Considering  aminoglycosides  and  fluroquinolones, Gentamycin  
and  Norfloxacin  were  highly  resistant. Ciprofloxacin  also  showed  
resistance  in  ESBL  isolates  compared  to  non  ESBL  isolates.  This  
can  be  explained  due  to co-resistance  of  ESBLs  with  
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aminoglycosides  and  fluroquinolones  because  of  plasmid  mediated  
gene  transfer.91 
Nitrofurantoin  can  be  considered  in  case  of  un complicated  
UTI  cases  and  Amikacin  along  with  cefoperazone  sulbactum  can  be  
used  in  treating  hospitalized  patients  with  complicated  UITs  with  
Meropenem  as  a  reserve  drug  where  response  to  all  other  drugs  are  
inadequate. 
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SUMMARY 
 A total  of  422  aseptically  collected  urine  specimens  were  
studied  during  the  period  of  one  year from  August  2013  to  
July  2014 in  Coimbatore  Medical  College  Hospital Coimbatore. 
 Out  of  422  samples, 206  were  from  males  and  216  were  from  
females. 
 Among  these  samples  141 (33.4%) yielded positive  growth  and  
278 (66.6%) samples  yielded  no  growth. 
 Among  the  positive  isolates  single organism  was  isolated  from  
131 (92.9%) samples  and  polymicrobial  growth  was  present  in  
10  (7.1%) samples. 
 Among  the  positive  isolates  Gram  negative  organisms 108 
(76.6%) predominate . 
 The  predominant  organisms  from  mixed  culture  was  maximally  
isolated  from  chromagar.(100%) rather  than  from  conventional  
media.   
 E.coli  was  the  most  common  isolate  accounting  for  54.6%  
followed  by  Klebsiella  which accounts  for  10.6%  of  the  
isolates. The  isolation  rate  of  Proteus  was 6.4% . Among  the  
Gram  positive  isolates  Enterococcus 14 (9.9%) was  the  
commonest  organism  isolated. 
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 Females  were  the  commonly  affected  group  with  a  male  to  
female  ratio  of  1:1.2  
 Among  males,  children  less than  10  years  and  elderly  above  60  
years  were  commonly  affected. Females  in  the  age  group  of  
21-50  were  more  commonly  affected. 
 The  isolation  of  organisms  from  Medicine  department (28.4%)  
was  higher compared  to  others.  From  the  out  patient  department  
the  isolation rate was 8.5%. 
 All  the organisms  were  isolated  from  chromagar  
media141(100%). Blood  agar  showed  100%  isolation  rate  of  all  
the  organisms  except  Enterococci ,Citrobacter  and  Enterobacter 
.MacConkey  agar  showed  85.8%  isolation  rate  of  organisms. 
 Uropathogens  were  most  sensitive  to Meropenem (100%),  
Amikacin (93%)  and  least  sensitive  to  Ampicillin  (16.4%).  
 Among  the  70  isolates  which  were  positive  in  screening  test 67  
were  confirmed  to  be  ESBL  producers. 
 Compared  to  Double  disc  approximation  test  E test  was  
considered the  most  sensitive   method  for  the  confirmation  of  
ESBL organisms. 
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 E.coli  (67.5%)was  the  most  common  organism  producing  
ESBLs.The  ESBL  positivity  rate  among  Klebsiella  and  Proteus  
was  66.7%  and  55.6%  respectively. 
 ESBL  organisms  were  common  in  children  below  10  years  and  
elderly  above  60  years. Males  were  commonly  affected  by  
ESBL  strains. 
 Medicine  department  was  the  commonest  among  other  
departments  where ESBL  organisms  were  isolated 
 E.coli  was  most  sensitive  to  Nitrofurantoin (98.7%) and  least  
sensitive  to  Ampicillin(19.5%). Klebsiella  was  most  sensitive  to  
cefoperazone sulbactum and  highly  resistant  to  Ampicillin. 
Proteus  was  highly  sensitive  to  Amikacin and cefoperazone 
sulbactum  (100%) and was  resistant  to  Ampicillin(93.3%)  and  
Cotrimoxazole (73.3%). 
 Pseudomonas  and  Acinetobacter  were  100%  sensitive  to  
Meropenem  and  cefoperazone sulbactum  . They  were  100%  
resistant  to  Norfloxacin  and  Nitrofurantoin. 
 Enterococci  showed  100%  sensitivity  to  Vancomycin and  
Nitrofurantoin. 
 Among  the ESBL  positive organisms  , coresistance  to  ampicillin, 
cotrimoxazole, and Ciprofloxacin  were found. 
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 ESBL  E.coli along  with  cefotaxime  showed  more  resistance  to  
Ampicillin,  Cotrimoxazole  ,Norfloxacin  and  Ciprofloxacin. 
 ESBL Klebsiella  showed  more  resistance  towards  Ampicillin, 
Cotrimoxazole  and  Ciprofloxacin. 
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CONCLUSION 
Urinary  tract  infections  are  the  most  common  infections  and  
urine  samples  are  among  the  most  numerous  specimens  sent  to  the  
laboratory.  The  aim  of  the  Microbiology  laboratory  is  to  reduce  
morbidity  through  accurate  and  timely  diagnosis  with  appropriate  
antimicrobial  sensitivity  testing . 
Our  study  compared  the  efficacy  of  chromogenic  agar  with  
conventional  media. The  chromogenic  media   supports  the  growth  of  
all  uropathogens.  The    media  prevents  the  spread  of  swarming  of  
Proteus. There  is   greater  differentiation  of  Gram  negative  bacteria  
and  Enterococci  can  be  easily  distinguished .  Direct  biochemical  
reactions  and  antibiotic  susceptibility  tests  can  be  performed  from  
the  primary  plate  itself  when  mixed  pathogens  are  present. This  in  
turn  also reduces  the  turnaround  time. Hence  chromogenic  media  can  
be  used  as  a  single  medium  for  the  isolation  of  uropathogens. 
       Escherichia  coli  is  the  predominant  isolate  from  urine  
specimens.  It  is  also  the  most  common  ESBL  producer  in  our  
study.  Multidrug  resistance  is  significantly  higher  in  ESBL  positive  
isolates. Knowledge  of  the  prevalence  of  ESBLs and  resistance  
pattern  of  bacterial  isolates  are  important in  the  prevention  of  the 
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emergence  and  spread  of  resistance  pattern  among  bacterial   
pathogens. 
An  easy ,rapid  and  reproducible  method  has  to  be  adopted  in  
the  laboratory  to  detect  ESBL  isolates.  Our study  suggests  that even  
though   E test  is  superior  to   DDST, because  of  its  simplicity   it   
can  also  be  adopted  as  a  method  of  ESBL  detection.    
Though  ESBL  isolates  are  more  susceptible  to  Meropenem,  
for  urinary  isolates  other  drugs  like  Nitrofurantoin  and  Amikacin  
can  be  prescribed. Unnecessary  usage  of  cabapenems   will  lead  to  
its  resistance  which  is  an  alarming   global  threat  today.   There  is  
also  associated  coresistance   of  non  beta lactam  antibiotics  like  
Norfloxacin, Cotrimoxazole and  Gentamycin  which  has  been  observed  
among  the  ESBL  positive  isolates.  Hence  they  can  no  longer  be  
prescribed  as  an  empirical  therapy. 
It  is  also  concluded  that  ESBL detection  for  uropathogens  
along  with  antibiotic  sensitivity  testing  is  mandatory  in  all  the  
laboratories  to  prevent  morbidity  and mortality .  
 Strict  infection  control  policy  in  hospitals  along  with  
antibiotic  stewardship  programs  can  limit  the  spread  of  these  multi  
drug  resistant  organisms.  New  antibiotic  policy  has  to  be  formulated  
and  adopted  in  the  hospitals  to  prevent  the  spread  of  these  
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organisms. Various  measures  such  as  correct  hand  washing  
procedures,  strict  asepsis  during  any  invasive  procedures  in  hospitals  
can  prevent  the  spread  of  these  organisms.  Since  there  are  
possibilities  of  occurrence  of  new  variants,  which  may  result  in  
serious  therapeutic  problems  in  the  future,  all  the  control  measures  
have  to  be  followed strictly. 
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ANNEXURES 
APPENDIX -1 
HiCrome  UTI  Agar, Modified   M1418 
Ingredients  :                                              Gms/Litre 
Peptic  digest of  animal  tissue                  18.00 
Casein  enzymic  hydrolysate                       4.00 
Beef  extract                                                  6.00 
Chromogenic  mixture                                 12.44 
Agar                                                            15.00 
Final   pH    7.2	∓0.2 
Directions:  
Suspend  56.94  grams  of  M 1418 in  1000ml  distilled  water. 
Heat to  boiling  to  dissolve  the  medium  completely. Sterilize  by  
autoclaving  at  15Ibs  pressure  (121◦C )  for  15  minutes. Cool  to  45-
50◦C and  pour  into  sterile  petri  plates. 
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N
G
2
M
alarvizhi
28
F
O
G
Fever
N
N
G
N
G
N
G
3
Shalini
7
Fch
B
M
W
Fever
P
G
W
C
LF
Pink C
olony
E.coli
A
K
,G
,C
FS,N
IT ,M
R
P                     
C
IP,N
X
,C
O
T,A
M
C
,A
,C
TX
N
P
4
R
agupathy
45
M
M
edical w
ard
Fever
N
N
G
N
G
N
G
5
V
eeram
m
al
33
F
O
G
U
TI
N
N
G
N
G
N
G
6
N
aveenkum
ar
10
M
ch
B
M
W
Fever
N
N
G
N
G
N
G
7
Pachiam
m
al
44
F
Fever O
P
U
TI
P
G
W
C
FLF
Pink C
olony
E.coli
A
K
,G
,C
FS,N
IT,C
O
T,M
R
P                       
C
IP,N
X
,C
TX
,A
M
C
,A
P
P
8
Sanjay
9
M
ch
Paed O
P
Fever
P
G
W
C
FLF
Pink+B
lueC
olony
E.coli
A
K
,G
,C
FS,N
IT,C
O
T,C
TX
,A
,C
IP ,A
M
C
,M
R
P                      NX
N
N
9
A
inyram
4
M
ch
Paed O
P
Phim
osis
P
G
W
C
FLF
Pink C
olony
E.coli
A
K
,G
,C
FS,N
IT,M
R
P                       
C
IP,N
X
,C
O
T,C
TX
,A
M
C
,A
P
P
10
Sujithra
3
Fch
Paed O
P
Fever
N
N
G
N
G
N
G
11
Seenu
2
M
ch
Paed O
P
Fever
P
N
G
LF
E.coli+Tiny blue 
colony
M
G
/Enterococci
A
K
,N
IT,V
A
N
N
X
,C
O
T,C
IP,A
M
C
,A
12
M
ekala
6
Fch
Paed O
P
Fever
N
N
G
N
G
N
G
13
M
ariam
m
al
72
F
Fever O
P
U
TI
N
N
G
N
G
N
G
14
A
shok kum
ar
17
M
M
edicine O
P
U
TI
N
N
G
N
G
N
G
15
N
andhini
7
Fch
Paed O
P
Fever
N
N
G
N
G
N
G
16
Jam
ila
55
F
M
edicine O
P
U
TI
N
N
G
N
G
N
G
17
A
nitha R
ani
29
F
M
edicine O
P
U
TI
N
N
G
N
G
N
G
18
Easw
ari
25
F
O
G
 w
ard
U
TI
PIH
P
G
W
C
N
LF
B
row
nish tinged 
colony
Proteus m
irabilis
A
K
,G
,C
FS,C
IP,N
X
 
,C
TX
,M
R
P                      
C
O
T,A
M
C
,A
N
N
19
Jagadeesw
aran
1
M
ch
PIC
U
 
Fever
N
N
G
N
G
N
G
20
Pugalendi
5
M
ch
PIC
U
 
Fever
N
N
G
N
G
N
G
21
Indum
athi
22
F
O
G
 w
ard
Fever
N
W
O
C
+G
W
C
N
LF
Sm
all C
ream
 
colony+ Pink colny
M
G
/C
andida
22
Soundarraj
10
M
ch
B
M
W
Fever
N
N
G
N
G
N
G
23
Sandhya
19
F
O
G
 w
ard
U
TI
N
2 Types
FLF+M
L
F
Pink+B
lueC
olony
E.coli
A
K
,G
,C
FS,N
IT,C
IP,N
X
 
,C
TX
,A
M
C
 ,M
R
P                     CO
T,A
N
N
24
Sijo
10
M
ch
Paed O
P
U
TI
N
2 Types
FLF+M
L
F
Pink+B
lueC
olony
E.coli
A
K
,G
,C
FS,N
IT,C
IP,A
M
C
,M
R
P
C
TX
,C
O
T,A
,N
X
N
P
25
V
asantha 
m
allika
4
Fch
Paed O
P
Fever
N
N
G
N
G
N
G
26
Sulim
an
43
M
M
edicine O
P
Fever
N
N
G
N
G
N
G
27
R
agum
an
10
M
ch
B
SW
Phim
osis
N
N
G
N
G
N
G
A
ST
 Pattern
28
Shanm
ugavel
10
M
ch
B
SW
Epididim
oorchitis
P
W
O
C
N
G
sm
all C
olourless 
colony
C
O
N
S
A
K
,G
,N
IT,A
M
C
,A
N
X
,C
O
T,C
IP
29
R
asidha parveen
12
Fch
B
SW
Fever
N
N
G
N
G
N
G
30
G
opinath
9
M
ch
B
SW
Phim
osis
N
N
G
N
G
N
G
31
Sekaran
47
M
M
edicine O
P
Fever
N
N
G
N
G
N
G
32
Pandian
55
M
M
edical w
ard
Fever
C
O
PD
P
G
W
C
LF
B
lue C
olony 
K
lebsiella
A
K
,G
,C
FS,M
R
P
N
IT,A
M
C
,N
X
,C
IP,C
TX
,C
O
T,A
P
P
33
K
aruppusam
y
60
M
M
edicine O
P
U
TI
D
M
N
W
O
C
N
G
N
G
34
Sivakum
ar
9
M
ch
B
SW
Phim
osis
N
N
G
N
G
N
G
35
N
agan
73
M
M
edical w
ard
Fever
D
M
P
G
W
C
N
LF
B
row
nish tinged 
colony
Proteus m
irabilis
A
K
,G
,C
IP,C
FS ,M
R
P               NX
,C
O
T,A
M
C
,C
TX
,A
P
P
36
A
rusam
y
65
M
U
rology w
ard
Stricture 
urethra
P
G
W
C
LF
Pink colony
E.coli
A
K
,G
,C
IP,A
M
C
,N
X
  ,M
R
P              
N
IT,C
FS,C
O
T,C
TX
,A
P
P
37
M
areesw
aran
30
M
M
edicine O
P
N
N
G
N
G
N
G
38
B
alusam
y
63
M
U
rology op
U
TI
P
G
W
C
-
2types
LF+N
LF
Pink+B
lueC
olony
K
lebsiella
A
K
,G
,C
FS,C
TX
,C
IP,N
IT,A
M
C
,M
R
P
A
,C
O
T,N
X
N
N
39
R
am
akrishnan
14
M
M
edicine O
P
Fever
N
N
G
N
G
N
G
40
Saravanavel
6
M
ch
Paed op
U
TI
N
N
G
N
G
N
G
41
Pushpalatha
43
F
M
edicine O
P
U
TI
P
W
O
C
-
M
icrococci
N
G
N
G
42
Elachiappa G
r
70
M
U
rology op
B
PH
N
N
G
N
G
N
G
43
R
am
asam
y
32
M
U
rology op
Stricture 
urethra
P
G
W
C
LF
Pink colony
E.coli
A
K
,G
,N
IT,C
FS,M
R
P
N
X
,C
O
T,A
M
C
,C
TX
,C
IP,A
P
P
44
A
njali
22
F
O
G
 op
U
TI
A
nem
ia
N
N
G
N
G
N
G
45
K
aliam
m
al
23
F
M
edical w
ard
Pyelonep
hritis
P
W
O
C
N
G
sm
all C
olourless 
colony
Staphylococcus 
aureus
A
K
.N
IT,A
M
C
,C
IP,A
,C
O
T
N
X
,G
46
K
atheeja 
parveen
23
F
O
G
Fever
A
nem
ia
N
N
G
N
G
N
G
47
D
urgesw
ari
3 m
on
Fch
B
SW
Fever
P
G
W
C
LF
Pink C
olony
E.coli
A
K
,G
,N
IT,C
FS,C
TX
 
,A
M
C
,A
,M
R
P
C
IP,C
O
T,N
IT
N
N
48
A
nitha
40
F
M
edical w
ard
Fever
R
ecurre
nt U
TI
P
G
W
C
N
G
Tiny blue 
colony+pink colony
M
G
/Enterococci
A
K
,N
IT,G
,V
A
N
N
X
,C
O
T,C
IP,A
M
C
,A
49
R
agavendra
2
M
ch
PIC
U
Fever
P
G
W
C
+W
O
C
N
G
Pink+B
lueC
olony
 E.coli
A
K
,G
,N
IT,C
IP,C
FS,M
R
P
C
TX
,C
O
T,N
X
,A
M
C
,A
P
P
50
A
bdulla
46
M
N
ephro w
ard
Fever
N
N
G
N
G
N
G
51
N
izam
24
M
M
edical w
ard
Fever
N
N
G
N
G
N
G
52
Senthil
35
M
Surgery w
ard
Fever
N
N
G
N
G
N
G
53
N
arayanan
73
M
Surgery w
ard
Fever
P
G
W
C
 2 
TY
PE
LF
Pink+B
lueC
olony
E.coli
A
K
,G
,C
O
T,N
IT,N
X
,C
TX
,C
I
P,C
FS,A
M
C
,A
,M
R
P
N
N
54
Lakshm
ipriya
19
F
O
G
U
TI
N
N
G
N
G
N
G
55
V
ignesh
12
M
ch
PIC
U
Ectopia 
vesicae
P
G
W
C
N
LF
Pale colony w
ith 
brow
nish tinge
Proteus m
irabilis
A
K
,G
,C
IP,C
FS,M
R
P                NX
,C
O
T,C
TX
,A
,A
M
C
P
P
56
Esw
aran
37
M
IM
C
U
Fever
N
N
G
N
G
N
G
57
A
yyasam
y
45
M
U
rology  w
ard
U
TI
P
Tiny 
W
O
C
+G
W
C
N
G
Pink+Tiny blue 
colony
M
G
+Enterococci
A
K
,N
IT,V
A
N
,C
IP
N
X
,C
O
T,A
M
C
,A
58
Sahana
2
Fch
PIC
U
U
TI
N
N
G
N
G
N
G
59
G
anesh
29
M
M
edicine O
P
Fever
N
N
G
N
G
N
G
60
Saleem
a
10
Fch
Paed op
U
TI
N
N
G
N
G
N
G
61
B
avani
10
Fch
Paed O
P 
Fever
N
N
G
N
G
N
G
62
Jeyalaxm
i
41
F
M
edical w
ard
Fever
P
G
W
C
N
LF
Pink C
olony
E.coli
A
K
,G
,C
O
T,N
IT,N
X
,C
TX
,C
I
P,C
FS,A
M
C
,A
,M
R
P
N
N
63
Safrene
2
F
PIC
U
 
Fever
N
N
G
N
G
N
G
64
Thebatham
m
al
75
F
M
edical w
ard
Fever
D
M
P
W
O
C
 2 
Types
N
G
Tiny blue + 
C
olourless colony 
E.coli
A
K
,G
,C
IP,A
M
C
,C
FS,N
IT,M
R
P
C
O
T,N
X
,A
,C
TX
P
P
65
Palany
65
M
M
edical w
ard
Fever
D
M
P
G
W
C
LF
Pink C
olony
E.coli
A
K
,G
,N
IT,C
FS,N
X
,M
R
P
C
IP,C
TX
,C
O
T,A
M
C
,A
N
P
66
A
ntony
67
M
M
edical w
ard
Fever
C
O
PD
N
N
G
N
G
N
G
67
M
adesh
60
M
U
rology O
P
Fever
N
N
G
N
G
N
G
68
M
anjula
21
F
O
G
Fever
P
G
W
C
N
LF
N
on transparent 
cream
y w
hite
A
cinetobacter
A
K
,G
,C
IP,C
TX
,C
FS,M
R
P
N
IT,C
O
T,N
X
.
69
Pandian
67
M
U
rology O
P
Fever
N
N
G
N
G
N
G
70
Palani
50
M
U
rology O
P
Stricture 
urethra
N
N
G
N
G
N
G
71
R
ubasree
20
F
O
G
Fever
N
N
G
N
G
N
G
72
M
arudhachalam
40
M
U
rology O
P
Fever
N
N
G
N
G
N
G
73
A
m
m
asai
55
F
M
edicine O
P
Fever
N
N
G
N
G
N
G
74
Senthilvel
44
M
U
rology O
P
Fever
N
N
G
N
G
N
G
75
R
ajagopal
74
M
Surgery w
ard
Fever
N
N
G
N
G
N
G
76
Pushpa
43
F
G
ynaec w
ard
Fever
N
N
G
N
G
N
G
77
Palaniam
m
al
65
F
U
rology O
P
U
TI
P
G
W
C
LF
Pink C
olony
E.coli
A
K
,G
,C
IP,C
FS,N
IT 
,A
M
C
,M
R
P
C
TX
,C
O
T,N
X
,A
P
P
78
Poornesh
3
M
ch
Paed O
P
Fever
N
N
G
N
G
N
G
79
Pradeep
31
M
IM
C
U
Fever
N
N
G
N
G
N
G
80
K
adheer
65
M
Surgery w
ard
U
TI
P
G
W
C
LF 
2TY
PES
Pink+B
lueC
olony
E.coli
A
K
,G
,C
IP,C
FS,N
IT,A
M
C
,M
R
P
C
O
T,N
X
,A
,C
TX
P
P
81
Sudha
27
F
Surgery w
ard
Fever
N
N
G
N
G
N
G
82
Safreena
2
Fch
B
M
W
Fever
P
G
W
C
 2 
TY
PES
M
LF+LF
Pink+tiny B
lue 
C
olony
M
G
83
Sindhu
23
F
O
G
/LW
Fever
N
N
G
N
G
N
G
84
R
avi
35
M
M
edical w
ard
Fever
P
G
W
C
+W
O
C
LF
W
O
C
+Pink colony
E.coli
A
K
,G
,C
IP,C
FS,C
TX
,N
IT,C
O
T,A
M
C
,M
R
P
A
,N
X
,
N
N
85
D
inesh
2
M
ch
PIC
U
Fever
P
G
W
C
LF
Pink colony
E.coli
A
K
,G
,C
IP,N
X
,N
IT,C
FS,M
R
P
A
M
C
,C
TX
,C
O
T,A
P
P
86
Shanthi
22
F
O
G
/LW
Fever
N
N
G
N
G
N
G
87
Elizabath
24
F
O
G
 O
P
U
TI
N
N
G
N
G
N
G
88
Sundari
32
F
M
edicine O
P
U
TI
N
N
G
N
G
N
G
89
Y
asararafath
5
M
ch
Paed O
P
Fever
N
N
G
N
G
N
G
90
Shanthanu
3
M
ch
Paed op
U
TI
P
Tiny 
W
O
C
+G
W
C
N
G
Pink+Tiny blue 
colony
M
G
/Enterococci
A
K
,N
IT,V
A
N
N
X
,C
O
T,C
IP,A
M
C
,A
91
H
am
u
8
M
ch
Paed op
N
N
G
N
G
N
G
92
Soujanya
9
Fch
PIC
U
N
N
G
N
G
N
G
93
R
aj kum
ar
47
M
M
edical w
ard
Fever
N
N
G
N
G
N
G
94
B
/O
 M
eenakshi
2m
on
M
ch
B
M
W
Fever
P
G
W
C
FLF
B
lue C
olony 
K
lebsiella
N
IT,N
X
,C
IP,A
K
,C
FS,M
R
P
C
O
T,C
TX
,A
M
C
,G
,A
P
P
95
V
asudevan
62
M
Surgery w
ard
Fever
N
N
G
N
G
N
G
96
K
avitha
33
F
N
ephro w
ard
Fever
N
W
O
C
+G
W
C
N
LF
Pink+sm
all 
C
olourless colony
M
G
/C
andida
97
Sanddep
3
M
ch
B
M
W
Fever
N
N
G
N
G
N
G
98
G
ow
ri
12
Fch
PIC
U
U
TI
B
ow
el  perforation
N
N
G
N
G
N
G
99
D
arnika
18 M
on
Fch
B
M
W
Fever
P
G
W
C
+W
O
C
N
LF+M
L
F
Pink + C
olourless 
colony
M
G
100
A
jm
el
10
M
ch
PIC
U
Fever
N
W
O
C
N
LF
sm
all C
olourless 
colony
C
andida
101
K
arpagam
25
F
O
G
/LW
Fever
N
N
G
N
G
N
G
102
C
hristoper
11
M
ch
B
M
W
Fever
N
N
G
N
G
N
G
103
Savithri
35
F
O
G
U
TI
N
N
G
N
G
N
G
104
K
ousik
3
M
ch
B
M
W
Fever
N
W
O
C
(M
icr
ococci)
N
G
N
G
105
N
isw
an
2 M
on
M
ch
B
SW
Post 
pyeloplas
ty
P
G
W
C
M
LF
B
lue C
olony 
K
lebsiella
C
FS,M
R
P
A
K
,G
,C
O
T,A
M
C
,N
IT,N
X
,C
IP,C
T
X
,A
P
P
106
C
hinu
54
M
U
rology w
ard
stricture 
urethra
N
N
G
N
G
N
G
107
Jithish Sriram
10
M
ch
PIC
U
 
N
N
G
N
G
N
G
108
D
ivya
10
Fch
PIC
U
 
Fever
N
N
G
N
G
N
G
109
A
rhhanari
75
M
 
U
rology  w
ard
B
B
H
N
N
G
N
G
N
G
110
M
agudesw
ari
12
Fch
PIC
U
 
M
eningiti
s
N
W
O
C
N
LF
sm
all C
olourless 
colony
C
andida
111
Prakash
9
M
ch
Surgery w
ard
Fever
N
N
G
N
G
N
G
112
Sabharish
5 M
on
M
ch
PIC
U
 
Fever
P
G
W
C
M
LF
Pink C
olony
E.coli
A
K
,G
,N
IT,C
FS,M
R
P
C
TX
,C
O
T,N
X
,C
IP,A
M
C
,A
P
P
113
Sarasw
athi
42
F
M
edical w
ard
U
TI
P
G
W
C
N
LF
B
row
nish tinged 
colony
Proteus m
irabilis
A
K
,G
,C
IP,N
X
,C
FS,C
TX
,A
M
C
,A
,M
R
P
N
N
114
K
arthikeyan
7
M
ch
PIC
U
 
Fever
N
N
G
N
G
N
G
115
K
rithika
10
Fch
Paed O
P
Fever
N
N
G
N
G
N
G
116
G
opal
52
M
M
edicine O
P
Fever
N
N
G
N
G
N
G
117
Thassam
a
5
Fch
Paed O
P
U
TI
N
N
G
N
G
N
G
118
Sundaram
58
M
M
edical w
ard
Fever
N
N
G
N
G
N
G
119
Satish
9
M
ch
PIC
U
 
Fever
N
W
O
C
(M
icr
ococci)
N
G
N
G
120
Y
asm
in
5
Fch
Paed O
P
Fever
N
N
G
N
G
N
G
121
B
huvanesw
ari
32
F
O
G
/LW
Fever
N
N
G
N
G
N
G
122
A
ntony D
aisy
26
F
Fever O
P
Fever
N
W
O
C
(M
icr
ococci)
N
G
N
G
123
G
ayathri
4
Fch
Paed O
P
Fever
N
N
G
N
G
N
G
124
K
anagaraj
29
M
Surgery w
ard
Fever
N
N
G
N
G
N
G
125
A
sm
a
33
F
O
G
 O
P
Fever
N
N
G
N
G
N
G
126
Sudha
20
F
O
G
 w
ard
Fever
N
W
O
C
(M
icr
ococci)
N
G
N
G
127
Prabu
31
M
M
edical w
ard
Fever
P
G
W
C
 3 
Types
LF + 
M
LF
Pink + B
lue C
olony
M
G
128
Shanm
ugam
55
M
U
rology  O
P
U
TI
N
N
G
N
G
N
G
129
Thulasi
73
F
M
edical w
ard
U
TI
P
G
W
C
FLF
Pink colony
E.coli
A
K
,G
,C
O
T,N
IT,C
TX
,C
IPC
F
S,A
M
C
,A
,M
R
P
N
X
N
N
130
B
alu
50
M
M
edicine O
P
Fever
N
N
G
N
G
N
G
131
K
eerthana
6
Fch
B
M
W
Fever
N
N
G
N
G
N
G
132
M
ani
29
M
M
edicine O
P
Fever
N
N
G
N
G
N
G
133
Sahul
5
M
ch
Paed O
P
Fever
N
N
G
N
G
N
G
134
A
sw
in
4
M
ch
Paed O
P
Fever
N
N
G
N
G
N
G
135
Jeevitha
15 M
on
Fch
PIC
U
 
Fever
N
N
G
N
G
N
G
136
Jerina B
egam
4
Fch
PIC
U
 
Fever
N
N
G
N
G
N
G
137
M
eganathan
32
M
M
edical w
ard
Fever
N
N
G
N
G
N
G
138
Periasam
y
42
M
U
rology O
P
U
TI
B
PH
P
G
W
C
LF 
Pink C
olony
E.coli
A
K
,G
,N
IT,C
FS,M
R
P
N
X
,C
IP,C
O
T,C
TX
,A
M
C
,A
P
P
139
D
anush
2
M
PIC
U
 
Fever
N
N
G
N
G
N
G
140
A
nandhi
32
F
Surgery w
ard
U
TI
N
N
G
N
G
N
G
141
G
anesan
49
M
U
rology w
ard
U
TI
N
N
G
N
G
N
G
142
Subbian
77
M
U
rology w
ard
U
TI
N
N
G
N
G
N
G
143
M
ailam
m
al
60
F
U
rology w
ard
U
TI
P
G
W
C
N
LF
Pink C
olony
E.coli
A
K
,G
,C
IP,N
X
,N
IT,C
FS,C
T
X
,A
M
C
,A
,C
O
T,M
R
P
N
N
144
K
anagavel
83
M
U
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KEY TO MASTER CHART 
UTI   - Urinary tract infections 
E.coli     - Escherichia coli  
CONS   - Coagulase Negative Staphlococcus 
MAC    - MacConkey agar 
BAP    - Blood Agar Plate 
FLF    - Flat Lactose Fermenting Colonies 
NLF    - Non Lactose Fermenting Colonies 
LF   - Lactose Fermenting Colonies 
GWC   - Greyish White Colonies 
WOC   - White Opaque Colonies 
PICU    - Paediatric Intensive Care Unit 
LW    - Labour Ward 
BSW    - Baby Surgical Ward 
GUS    - Genito Urinary Surgery 
FM   - Female Medical Ward 
MM   - Male Medical Ward 
N   - Negative 
P   - Positive 
ESBL   - Extended Spectrum Beta Lactamases 
AK   - Amikacin 
G   - Gentamycin 
NIT   - Nitrofurantoin 
COT   - Cotrimoxazole 
AMC   - Amoxy clavulanic acid 
CIP    - Ciprofloxacin 
NX    - Norfloxacin 
CTX    - Cefotaxime 
CFS    - Cefoperazone sulbactum 
A     - Ampicillin 
NG     - No growth 
MG       - Mixed growth 
DM    - Diabetes mellitus  
CKD    - Chronic Kidney Disease 
DKA    - Diabetic Keto Acidosis 
